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G-proton coupled receptors (GPCRs) are excellent drug targets that occupy a central 
position in the physiology of insects and are involved in transmission of signal from 
the extracellular to the intracellular side of the cell.    Adipokinetic hormone receptors 
(AKHRs) are GPCRs that mediate physiological functions of the neurohormones, 
adipokinetic hormones (AKHs) that regulate mobilisation of energy reserves during 
mosquito flight.   Ligand binding to GPCRs depends on the three dimensional (3D) 
structures of the receptors but to date no crystal structures of insect GPCRs are 
available.   This work focused on building molecular models of AKHR from the 
genome of the malaria mosquito, identifying its binding site and studying the 
conformational and structural changes during molecular dynamics of the active and 
inactive receptor.    
Homology modelling was used to build the helices based on the crystal 
structures of rhodopsin and beta2-adrenergic receptor (β2AR).  The loops were built 
separately and joined to their respective helices.   Molecular dynamics was used for 
conformational search of the loops.  The two resulting 3D structures of the GPCR 
from the malaria mosquito had similar overall structures.   However, the β2AR-based 
structure had an ‘open’ conformation in the extracellular region, whilst the rhodopsin-





NMR restrained molecular dynamics was used to determine the solution 
conformation of AKH-I from Anopheles gambiae (Anoga_akh).   Docking 
calculations of this peptide and the decapeptide, Del_CC, from the blister beetle 
showed that helices 2,3,5,6, and 7, and the extracellular domains defined the binding 
pocket of AKHR.    The ‘open’ AKHR model provided easy access to the binding site 
and had higher affinity for the ligands than the ‘closed’ structure.   During molecular 
dynamics, after binding of the agonist, the receptor binding pocket closed to protect 
the ligand.   At the same time the intracellular region opened.  Although conversion of 
the receptor from inactive to active state was slow with Anoga_akh, the receptor had a 
higher affinity for the ligand than for Del_CC as indicated by estimated free energy of 
binding, -47.3 kJ/mol and -38.5 kJ/mol respectively.  The protein-ligand complexes 
were stabilised by an intense network of H-bonds, salt bridges and hydrophobic 
interactions.  Tyr285 (H6) played an important role in binding Del_CC, whilst ILe106 
(H2) was pivotal in binding Anoga_akh.       
Since AKHR facilitates energy mobilisation during insect flight, knowledge of 
the 3D structure and binding pocket of the receptor from the malaria mosquito could 
lead to structure-based design of non peptide antagonists that prevent binding of AKH 
molecules.  This would stop generation of energy for the mosquito to fly and pave the 



































GPCRs - G-protein coupled receptors 
MD  - Molecular dynamics 
AKH  - adipokinetic hormones 
AKHR - adipokinetic hormones 
β2AR   - beta2-adrenergic receptor 
7TMs - seven transmembrane helices 
ECL  - extracellular loop 
ICL - intracellular loop 
 
Amino acids (Residues) 
Name  Three letter Name  Symbol 
Alanine  Ala      A 
Aspartic acid  Asp      D 
Asparagine  Asn      N 
Arginine  Arg      R 
Cysteine  Cys      C 
Glutamic acid  Glu      E 
Glutamine  Gln      Q 
Glycine  Gly      G 
Histidine  His      H 
IsoLeucine  Ile      I 
Leucine  Leu      L 
Lysine   Lys      K 
Methionine  Met      M 
Phenylalanine  Phe      F 
Proline   Pro      P 
Serine   Ser      S 
Threonine  Thr      T 
Trpptophan  Trp      W 
Tyrosine  Tyr      Y 


























































































































Insect flight is under hormonal control via adipokinetic hormones that regulate the 
mobilisation of energy reserves during flight.   Their action occurs through binding to 
G-protein coupled receptors, which occupy a central position in the physiology of 
insects and are excellent drug targets.   Binding of the hormone to a GPCR depends 
on the three dimensional structure (3D) of the receptor but to date no 3D structure of 
an insect G-protein coupled receptor (GPCR) is available.    
In this thesis, the first models of the 3D structures of a GPCR from the malaria 
mosquito are presented.   Molecular modelling of the receptor, using the primary 
sequence identified from the genome of Anopheles gambiae, was used to construct 
two models of its AKH receptor.   Homology modelling of the 7 transmembrane 
helical bundles of these two models was based on the crystal structures of beta2-
adrenergic receptor (β2AR) and rhodopsin.   The flexible loop regions were modelled 
using high temperature simulated annealing and constrained molecular dynamic 
simulations.   The two receptor models differ in a number of critical features, the most 
important of which is that the rhodopsin-based model has a ‘closed’ structure while 
the β2AR-based structure is ‘open’.   To mimic the receptor’s true environment, 
extensive molecular dynamic simulations were performed in an explicit membrane to 
determine stability and conformational changes during molecular dynamics.   
Docking calculations with insect adipokinetic hormones, showed that helices 
2, 3, 5, 6 and 7, and the extracellular domain of the receptor participate in hormone 





ligands, thus hormone binding was facilitated.   Molecular dynamics of the 
receptor/ligand complex have revealed that the inactive state of AKH receptor has an 
open conformation whilst the activated form takes up a closed conformation similar to 
rhodopsin.   Binding of the ligand involved ionic as well as hydrophobic interactions 
with residues in the helical bundle, for example Tyr285, and in the loop regions.   
Since this receptor is involved in generation of energy during insect flight, 
knowledge of its 3D structure and binding pocket could lead to the design of non-
peptide mimetics that can block the binding pocket and lead to the development of 
species specific insecticides.   Therefore, by using genomic information, the fight 
against malaria could be enhanced. 
1.2 The Mosquito, Anopheles gambiae and Malaria 
The mosquito, Anopheles gambiae, (Figure 1.1) is the World’s most efficient vector 








Figure 1.1: The mosquito, Anopheles gambiae, the major vector of the malaria 
parasite, Plasmodium falciparum. 
 
Malaria is endemic to large portions in Africa and is responsible for up to 500 million 






Saharan Africa [1,4].   The mosquito requires multiple human blood meals for its 
reproductive cycle and this favours the transmission of the malaria parasite to humans 
[3].   For this reason, it is important to control this insect so as to reduce the spread of 
malaria. 
Insecticide-based control measures are the primary way to kill mosquitoes that 
bite indoors and at night, but there is increasing resistance of A. gambiae to currently 
used insecticides like DDT, permethrin and deltamethrin [1,5,6].   These insecticides 
also have adverse side effects in humans, therefore there is an urgent need for 
continuous search for alternative insect specific insecticides.   The genome of 
Anopheles gambiae has recently been published [1], hence in this thesis utilisation of 
genomic information in designing new insecticides and identifying alternative targets 
is presented. 
1.3 Adipokinetic Hormones (AKHs) from Anopheles gambiae 
Important in the mosquito activity is its ability to fly and flight activity is under 
hormonal control via the adipokinetic hormones (AKHs) [7].   The hormones are all 
octa-, nano- or decapeptides with N-(pyroglutamate) and C-(amidate) termini and are 
highly homologous, for example, Del_CC (pQLAFSPNWGNa) and Term_HrTH 
(pQLAFSPNWa) from the blister beetle species [7,8].   Most of these hormones 
contain Phe, Pro and Trp at positions 4, 6 and 8 respectively, which is postulated to be 
important in hormone structure and receptor binding.   AKHs contribute to 
hemolymph sugar homeostatsis and are involved in the mobilisation of sugar and 
lipids from the fat body during energy-demanding activities, such as flight and 





As in most insects, two AKHs, octapeptide AKH-I (pQLTFTPAWa) and 
decapeptide, AKH-II (pQVTFSRDWNAa), have been identified in A. gambiae [9,11].   
These peptides were present in the freshly hatched larvae, heads and thoraces of 
pupae and adult mosquitoes.   AKH-I was found to be responsible for inducing 
mobilisation of carbohydrates and lipids during flight and therefore enhancing the 
flight activity of the female mosquito [9].   On the other hand AKH-II, which consists 
of Arg instead of Pro in position 6, had no effect on carbohydrate and lipid levels and 
hence did not influence flight performance [9].    
Commencement of flight activity induces the release of the hormones from the 
corpora cardiaca, a neurohemal gland connected to the insect brain, into the 
circulatory system [12].   Binding of the AKHs to their G- protein coupled receptor 
(GPCRs), at the fat body, triggers a number of coordinated signal transduction 
processes that ultimately result in the mobilisation of carbohydrates and lipid reserves 
as fuel for flight activity [3,7,8,9,11,12].   It has been suggested that studies of these 
receptors, that play an important role in processes central to vector capacity, would 
contribute to the development of a new generation of mosquito repellents, attractants, 
insecticides, as well as other types of antimalarial drugs [1,2,3].   These drugs would 
reduce the spread of malaria by reducing the effectiveness with which mosquitoes 
locate and feed on their human victim [1].    In this work a study of the 
physiologically important AKH GPCR that facilitates generation of energy during 





1.4 The G - protein Coupled receptors (GPCRs) 
1.4.1 Secondary Structure and Function 
GPCRs comprise the largest superfamily of membrane-bound proteins in animal 
genome [2,13-18] and share a similar overall tertiary structure characterised by highly 
conserved seven α -helices that span the cell membrane (7TMs), three extracellular 
(ECL) and three intracellular loops (ICL) that join the helices together, the N-
terminus and the C-terminus [13,14,16,19-23].   Due to the presence of the 7TMs, this 
family of proteins is also known as the 7-transmembrane receptors or heptahelical 
receptors [24].   The structural domains commonly found in these receptors are shown 












Figure 1.2: Schematic representation of the membrane topology of the human beta2-
adrenergic receptor.   Black lines indicate the localised transmembrane helices, light 
grey and dark grey show the core and the water-lipid interface regions of the lipid 
membrane, respectively.   The black circles in the each of the 7 transmembrane 






As shown in Figure 1.2, each helix consists of highly conserved residues, motifs and 
patterns for class A receptors, which are Asn (H1), Asp (H2), DRY (H3), Trp (H4), 
Pro (H5), CwxxY/F (H6) and NPxxY (H7), where x stands for any other residue 
[16,27,29,30].   Patterns are short sequence of continuous or discontinuous highly 
conserved amino acids in one helix and one GPCR class and motifs are described as 
continuous multiple-sequence regions that include conserved amino acids [30].  In 
addition the receptors are also characterised by disulphide bonds linking the first 
extracellular loop and the second extracellular loop that stabilise the helix bundles and 
also participate in ligand binding [19,16,23,25,26].   In β 2AR there are two such 
bridges between Cys106/Cys191 and Cys184/Cys190.  Rhodopsin however contains 
only one disulphide bond between Cys 110 and Cys187.    In the intracellular region, 
there is a palmitoylation site involving Cys341 in β2AR, and Cys322 and Cys323 in 
rhodopsin [19,25,26,31-34]. 
GPCRs form the largest family of proteins that comprise receptors for ~80% 
of hormones, neurotransmitters and neuromodulators with important physiological 
functions [27,35].   The family includes receptors that respond to a variety of 
endogenous agonists and antagonists such as amines, peptides, amino acids, 
glycoproteins, phospholipids, fatty acids, nucleotides, Ca2+ ions and sensory receptors 
[14,15,27].   These receptors transduce extracellular stimuli into intracellular signals 
when agonistic binding to the extracellular receptor results in conformational changes 
of the 7TMs, resulting in activation of a heterotrimeric G-protein and generation of a 
cascade of signalling pathway [2,14,13,36].   For this reason they are good drug 
targets.   In humans there is an estimated 948 GPCRs and about 50% of all targeted 
pharmaceuticals are active because of binding to GPCRs [4,15,37,38].   Therefore, 





1.4.2 Classification of GPCRs    
Although GPCRs do not share any overall sequence homology they contain the seven 
transmembrane α-helices as the only common structural feature to all receptors [22].  
Significant homology is however found within several sub-families which were 
formed based on their native ligands, phylogenetic analysis and their amino acid 
sequences [27].    Kolakowski, 1994 [39] first divided the receptors into six different 
families or classes.   Each family had >20% amino acid sequence identity within the 
7TMs.   Three major subfamilies were divided into Classes A, B and C.   Class A 
includes receptors related to rhodopsin and β2-AR, Class B comprises of receptors 
related to glucagons and receptors related to the metabotropic neurotransmitter 
receptors form Class C of GPCRs [22,27].   The minor classes D, E and F comprise 
the yeast pheromone receptors and the cAMP receptors respectively. 
 Class A (rhodopsin-like) GPCRs is the largest and most studied family and is 
divided into six major subfamilies, which are opsins, receptors for odorants, small 
endogenous agonists, peptides, leucine-rich repeat motif and protease-activating 
receptors [22,27].   The overall homology of these receptors is low and restricted to a 
number of highly conserved key residues and motifs, namely Asn (H1), Asp (H2), 
DRY (H3), Pro (H5), CWxxY (H6) and NPxxY (H7), as shown in Figure 1.2 [22,27].   
The high degree of conservation among these key residues suggests that they have an 
essential role for either the structural or functional features of the receptors.   All 
Class A receptors contain the residue, arginine, in the DRY motif at the cytoplasmic 
side of helix 3 (H3).    In addition, all Class A receptors have a disulphide bond that 
connects the second and third extracellular loops. 
 On the otherhand, Class B includes about 20 different receptors for a variety 





calcitonin and glucagons [22,27].   The disulphide bond is the only structural feature 
also found in Class B and the important DRY motif common to all Class A receptors 
does not exist in this family.   These receptors are characterised by a large (~ 100 
residues) extracellular amino terminus with several cysteines.   In contrast, Class C 
has an exceptionally long amino terminus of about 500-600 residues and include the 
metabotropic glutamate and γ-amino-butyric acid receptors, the calcium receptors and 
the taste receptors [22,23,27].   Class C receptors have two putative disulphide bond 
forming cysteines in ECL2 and ECL3 respectively.   The three classes do not share 
any conserved residues amongst themselves.   The recently published primary 
structure of AKH receptors in Anopheles gambiae has revealed that the receptor 
belongs to Class A GPCRs.  
1.4.2.1 AKH G-protein coupled receptors  
The first biochemical characterisation of AKH G-protein coupled receptors was 
performed for the tobacco hawk moth, manduca sexta, followed by cloning and 
identification of the receptors in the fruitfly, Drosophila melanogaster, the silkworm, 
Bomyx mori and the cockroach, Periplaneta Americana [10,19,12].   The receptors 
were found to be structurally and evolutionarily related to the gonadotropin-releasing 
hormone receptor from vertebrates [10].   AKH receptor cloned from Bomyx mori had 
48% sequence identity and 68% conserved residues similarity with receptor-1 of 
Drosophila melanogaster.   Both receptors had two potential glycosylation sites at the 
same position [10].   
From the recently published genome for A. gambiae 276 genes could be 
interpreted as putative neuropeptide receptors.  Of these, 25 were GPCRs belonging to 





the way for new ways of combating the spread of malaria with highly selective and 
environmentally friendly insecticides [4].   Thus, from orphan GPCRs of Anopheles 
gambiae, Kaufmann, C. & Brown, M. R [11] and Belmont, M. et al [4] identified the 
primary sequence of a putative AKH GPCR (AKHR), which belonged to Class A 












Figure 1.3: Primary sequence of adipokinetic hormone receptor (AKHR) from the 
malaria mosquito, Anopheles gambiae, extracted (Genbank database accession 
number AY298745).   The loop regions (black), helices 1 to 7 (red) and the highly 
conserved residues, patterns and motifs (blue) are as predicted by Belmont, M et al, 
2006 [4].   These regions were consistent with those predicted by Kaufmann and 
Brown, 2006 [11].  
 
The receptor had 354 residues and was highly concentrated in the head, thorax and 
abdomen of the mosquito [9,11] , where the fat body, involved in nutrient storage and 
metabolism, is distributed [12].   The putative AKH receptor from Anopheles gambiae 
has high sequence similarity to the receptor from Drosophila melanogaster [4,11].   















with 50 residues and a C-terminus of 27 residues, which is much shorter than in other 
AKH GPCRs [4,11].    The seven transmembrane helices contain residues, patterns 
and motifs commonly found in Class A GPCRs, shown in Table 1.1, where x 
represents any other residue. 




in Class A GPCRs 
Residues/Motifs/Patterns 
in AKHR 
1 N N 
2 LAxxD LAIAD 
3 (D/E)R(Y/H) DRY 
4 W W 
5 (F/Y)xxPxxxxxxxY YTFPLIVILYCY 
6 (F/YxxxWxPYY FVVCWTPYY 
7 (N/D)PxxY NPVVY 
 
These residues are believed to play an important role in stabilising the helical bundle 
through helical interactions.   In addition they are also crucial for ligand binding and 
receptor activation. 
 
1.4.3 Activation of Class A GPCRs  
Activation of GPCRs is induced by binding of a variety of ligands to the extracellular 
side of the receptor.   This results in diverse ligand – receptor interactions that cause 
changes in the conformation of the receptor molecule especially in the helix bundles 
[13,27].   Opsins, (rhodopsin and colour pigments), are different from other Class A 





11-cis-retinal, is covalently bound to the protein by a protonated Schiff base bond to 
the e-amino group of the Lsy residue in H7 [16,32,33,40].   When exposed to light, 
there is a change from 11-cis to an all-trans conformation of the ligand within 
femtoseconds [13,16,33,32].   Activation of these receptors involves the neutralisation 
of the Schiff’s base counter ion, and a conformational change in the intracellular side 
associated with protonation of two cytoplasmic acidic residues [27].   In bovine 
rhodopsin, it has been proved that photoactivation can induce movements of helix 3 
(H3) and helix 6 (H6), relative to the rest of the 7-helix bundle, a significant rigid 
body movement of H6 in a clockwise direction when viewed from the extracellular 
side, and movement of the cytoplasmic end of the helix away from H3 that results in 
the disruption of the ionic bonds involving the highly conserved Arg residue in H3 
[27]. 
Small endogenous and exogenous receptors are activated by noncovalent 
binding of specific agonists to the upper part of the helix bundles.   Spectroscopic 
analysis of the fluorescent antagonist, carazolol, in β2AR has shown that the binding 
sites of these receptors are buried deep inside the helices [41].   Molecular biology 
techniques have also illustrated that the binding sites for a number of small agonists 
like biogenic amines, adenosine, nucleotides and 3-peptide thyrotropin releasing 
hormone are between H3, H4, H5, H6 and H7 [42-46].   In addition, site-directed 
mutagenesis experiments have shown that some residues in the extracellular loop 
domains, eg ECL2 are important for binding of agonist and antagonists, [47].   The 
presence of the disulphide bond between ECL2 and ECL3 would covalently link the 
loop in close proximity to the binding site.   Kim et al, 1996 [47], highlighted that the 
second extracellular loop may form a lid over the bound ligand and keep it in the 





ECL1 and ECL3 may also play an important role for receptor conformation [48], or 
form a channel for ligand entrance to the primary binding site [27].   Ligand 
channelling hypothesis has also been proposed for rhodopsin [49].   The ligands may 
enter their binding pockets after attraction and sequential interactions with a channel 
between ECL1 and ECLs/TMs at the entrance to the buried binding site within the 
helical bundle. 
Peptide receptors form the largest subfamily of Class A GPCRs and mediate 
important physiological roles of neurotransmitters, hormones, and paracrines [27].   
Mutational studies have shown that in many peptide receptors there is critical 
involvement of the extracellular domains for binding of the large peptide ligands [50-
54] and that these interact directly with residues in the N-terminus and the 
extracellular loop domains.   Amongst these are receptors for angiotension II, 
neuropeptide Y (NPY), chemokines, thyrotropin-releasing hormone (TRH) and 
gonadotropin releasing hormone (GnRH) [55-61].   Experimental results have also 
shown that residues in the upper parts of H2, H3, H5, H6 and H7 interact directly with 
certain neuropeptides, for example, in human, Y1NPY, δ  opiod, ETB endothelin 
[62,63,64].   Recently, docking calculations involving an insect peptide GPCR, 
pheromone biosynthesis activating neuropeptide receptor, have also indicated the 
importance of the extracellular domains in ligand binding [65,66,67].   The identified 
binding positions are different from the key positions believed to interact with ligands 
in the biogenic amine receptors [22]. 
GPCRs are believed to exist in equilibrium between the activated and the 
inactivated states.   There is interconversion between the two states upon ligand 
binding.   When bound to an agonist, the activated state is favoured leading to 





hand, inverse agonists bind to the receptor with higher affinity for the inactive state 
than the active state [69], whereas neutral antagonists bind with equal affinity for the 
activated and the inactive states and have no effect on the constitutive activity.  
1.4.3.1 G-proteins and signal transduction 
GPCRs act on the heterotrimeric G-proteins as guanine-nucleotide exchange factors 
[22,27].   There are three subunits of heterotrimeric G-proteins, α , β  and γ .   The 
receptor is bound to the GDP-ligand α -subunit and this association is greatly 
enhanced by association with βγ -subunits [27].   Upon activation, conformational 
changes occur in the GPCR molecule resulting in increased affinity of the associated 
G-protein α -subunit leading to release of GDP and the immediate binding of GTP 
[22,27,70].   Affinity for α-subunit for βγ-subunits decreases and the GTP-bound form 
of the α-subunit dissociates from the receptor as well as from the βγ - dimer.   The 
released βγ -dimer can modulate several cellular signalling pathways including 
stimulation or inhibition of adenylate cyclases, tyrosine kinases, GPCR kinases 
(GRKs) and activation of phospholipases, as well as regulation of potassium and 
calcium channel activity resulting in cellular functions [71,72].    
To quench the activation, GTP is hydrolysed to GDP, leading to resuscitation 
of α -GDP and βγ-subunits and the receptor reverts back to the inactive state [27].   
The signal can also be terminated by reuptake and desensitisation of neurotransmitters 
or their precursor, or the degradation of neuropeptides by the cell surfaces proteinases. 
1.4.4 Three dimensional structures of GPCRs  
Three dimensional (3D) structures of receptors provide insight into the molecular 
basis of protein function for effective design of experiments like site-directed 





inhibitors [73].   Since it has been observed that small agonists and the majority of 
antagonists for GPCRs bind wholly to the transmembrane helices [13,16], and peptide 
hormones also bind to the extracellular domain [22,70], 3D structures of these 
receptors are crucial for ligand binding and signal transduction.  
1.4.4.1 Determination of 3D structures of GPCRs 
Despite their importance in physiological processes, very little information on the 3D 
structures of GPCRs, is available.   Experimental methods that include NMR and X-
ray crystallography, normally used in the determination of the 3D structures of 
substances, cannot be easily used to determine the 3D structure of GPCRs [15].   This 
is because the membrane-bound proteins are highly flexible and hence difficult to 
crystallise for application of X-ray crystallography [19,39,74,75].   On the other hand 
the large molecular size and low solubility [15,19,39,74,75] of the receptors make it 
impossible to apply NMR techniques.   Thus, to date, the only resolved crystal 
structures of the GPCR, are for the mammalian rhodopsin [16,18], and the human 
Beta2- adrenergic receptor (β2AR) [25,26].   However, the highly mobile third 
intracellular loop has been removed in both crystals.   For this reason, most known 
pharmaceuticals that target GPCRs are based on molecular models obtained from 
computational methods.  
1.4.4.1.1 Crystal structures of Rhodopsin and Beta2- adrenergic receptors 
Rhodopsin and β2AR have similar overall structures [14], and provide good templates 
for homology modelling of GPCRs [14,19,75].   The two receptors belong to Class A 
GPCRs [76], in which rhodopsin is a member of the opsin subfamily [19,26] and 







Rhodopsin is found in the retina of the eye and is structurally stabilised by a 
covalently bound ligand, 11–cis retinal [19, 28,29,36,75].    The first crystal structure 
of this receptor was resolved at 2.8 Ǻ  by Palczewski et al, [16] and deposited in the 
Protein Databank (PDB) as 1F88A (Figure 1.3a &b ).   The receptor had a total of 348 













Figure 1.3: Ribbon structures of the two crystal structures of GPCRs. a)  Side view of 
the structure of rhodopsin (PDB, 1F88A), showing the helices (cyan), the loops 
(brown) and two β-sheets (pink) in the second extracellular loop.   The loop forms a 
lid over the binding site to protect the bound ligand (not shown). b)  Extracellular 
view of rhodopsin indicating the arrangement of the helices.   c) Side view of β2AR 
(PDB, 2rh1A) indicating the helices (gold) and the loops (pink).   The second 
extracellular loop has a helix that keeps away from the binding pocket and d) shows 
the extracellular view of the molecule which illustrates the open conformation of the 







The crystal structure showed the packing of the seven transmembrane helices across 
the membrane, an eighth helix parallel to the membrane inside the cell, and the 
positions of the termini and the loop domains.   The binding site is covered by a β–
sheet lid formed by the second extracellular loop, (ECL2) and a cap–like structure 
formed by the N-terminus and the helix domain [19,20,26].   The disulphide bond is 
highly conserved in most GPCRs and is formed by Cys110 at the end of helix 3 and 
Cys187 in the second extracellular loop.     
As mentioned earlier this receptor is activated only by a photon of light that 
induces conformational changes in the bound ligand.   Crystallographic refinement 
produced the model of rhodopsin at resolution of 2.8Å (PDB code, 1HZX) [33].   
Okada et al refined the ground-state of rhodopsin to 2.6Å at which water molecules 
could be assigned to the helix bundle [32].   Up until 2007, this has been the only 
known crystal structure of a GPCR, that has been used as a template for building 3D 
structures of all most all GPCRs.  
 
Beta2-adrenergic receptor  
The crystal structure of β2AR was obtained at a resolution of 2.4Ǻ, by replacing part 
of the third extracellular loop of the receptor with T4 lysozyme to reduce its 
flexibility.   The structure was published in 2007 [19,25,26] (Figure 1.3c & d) and 
deposited in PDB as 2rh1A.    The receptor has a broader range of signalling 
behaviour,  couples to more than one G-protein and responds to a spectrum of many 
diffusible ligands.   The binding site was located in a similar position to that of 
rhodopsin [19,20].    In comparison to rhodopsin, it had a more open structure in the 
extracellular region of the helix bundle, with the second extracellular loop constrained 





Both β 2AR and rhodopsin, however, undergo similar conformational changes in the 
process of activation [19].   The structural differences between β2AR and rhodopsin 
helices clearly show that the two structures would predict quite different locations for 
the same residues when used as templates in homology modelling of the same GPCRs 
and hence give models with different structural features.  
Modelling results of large protein molecules like AKHR are largely dependent 
on the starting structure and may not be identical with the structure of AKHR or the 
AKHR/AKH determined by x-ray crystallography or by NMR spectroscopic methods. 
However, the crystal structures of rhodopsin and β2AR gave valuable information on 
the structure and activity of Class A GPCRs, and hence, facilitated structure-based 
drug design.   Therefore, the 3D structure of the adipokinetic hormone receptor from 
Anopheles gambiae, could give essential information for the design of non-peptide 
mimetics which can block the receptor binding pocket, reduce the amount of energy 
available for the mosquito to fly and hence prevent the transmission of malaria.  
1.5 Problem Statement and Research Motivation  
Despite their importance in physiological processes, very little is known about the 3D 
structures of insect GPCRs.   In fact, no crystal structures of these crucial receptors 
are known.   That is, to date the 3D structures of GPCRs for adipokinetic hormones 
from Anopheles gambiae and knowledge of their binding pockets are not available.   
This hinders the use of these receptors in structure-based drug design that could lead 
to production of alternative insecticides and identification of alternative targets.   
Since only two crystal structures of GPCRs, rhodopsin and Beta2-adrenergic 
receptor, have been resolved [16,19,25,26,28,32], in humans, ~50% of all known 





receptors [36,65,67,75-84].   Therefore, from an accurate model of AKHR, the 
binding site can be identified and this should facilitate structure-based design of non-
peptide ligands that can act with high potency at the receptor as antagonists and 
agonists [22].   These will lead to production of insect specific insecticides that reduce 
the vector capacity of the mosquito by reducing the amount of energy released during 
flight, thus enhancing the eradication of malaria.   To this reason, this thesis focuses 
on the determination of the 3D structure and location of binding site of adipokinetic 
hormones G-protein coupled receptors from the mosquito, Anopheles gambiae.  
1.6 Aims and Objectives 
Aims 
To determine the three dimensional structure of a GPCR, adipokinetic hormone 
receptor, from the malaria mosquito, Anopheles gambiae and to use this in docking 
studies to identify the hormone binding pocket. 
Objectives 
• Use the primary sequence of adipokinetic hormone receptor to build the three 
dimensional structure of the helix bundles using homology modelling based on 
the crystal structures of rhodopsin and beta2-adrenergic receptor. 
• Separately build the loop domains using molecular dynamic simulations.  
• Join the loops to their respective helices and optimise the final models of the 
adipokinetic hormone receptor in vacuum and then in an explicit 
membrane/water system. 
• Identify the binding pocket of the adipokinetic hormone receptor by 





conformational search of the bound receptor by molecular dynamic 
simulations. 
• Use NMR restrained molecular dynamics to determine the solution structure 
of an adipokinetic hormone from anopheles gambiae. 
• Perform docking calculations using the adipokinetic hormone receptor and 
hormone from anopheles gambiae. 
1.7 Questions addressed in the Thesis 
1. Are the three dimensional structures of adipokinetic hormone receptor based on 
rhodopsin and Beta2-adrenergic receptor molecules the same?   If not is there any 
relationship between the structures? 
2. What conformational and structural changes occur during molecular dynamic 
simulations of both models in their true, membrane environment?   How well do these 
changes correlate with experimental results on other GPCRs? 
3. How does the location of the binding site in adipokinetic hormone receptor 
compare to those in rhodopsin and Beta2-adrenergic receptor?   How does this 
position agree with experimental results from other peptide GPCRs? 
4. What are the free energies of binding of AKHs to the receptor and is the 
accessibility of the binding pocket the same for both the rhodopsin-based and the 
beta2-adrenergic-based structures?   If not, to what extent are they different? 
5. What conformational and structural changes occur during molecular dynamics of 
bound beta2-adenergic-based model?  
6. Is there any relationship between the inactive state of AKHR and the Beta2-
adrenergic-based structure, and between the active state and the rhodopsin-based 





1.8 Brief Overview of Chapters 
This thesis is made up of seven chapters. 
• Chapter one gives the introduction including review of AKHs and their 
GPCRs, problem statement, aims and objectives and thesis statement. 
• Chapter two gives a description of molecular modelling methods, docking and 
NMR experiments used in this thesis. 
Chapters three to six contain the bulk of the thesis.   Each chapter gives a summary, 
experimental procedures, equipments, results and discussion, and conclusions for the 
major achievements. 
• Chapter three focuses on molecular modelling of adipokinetic hormone 
receptor.  The results highlight the similarities and differences between the 
rhodopsin-based and the Beta2-adrenegic receptor-based models. 
• Chapter four describes molecular dynamic studies of the models in a 
membrane model.  Stability, conformational changes and role of the 
membrane during molecular dynamics of the receptor are given. 
• Chapter five concentrates on docking studies and molecular dynamic 
simulations of the bound receptor.   The results present the position of the 
binding pocket of the receptor as identified by an active hormone, Del_CC, 
accessibility of the site in both models and the change from open to closed 
conformation upon activation of the receptor. 
• Chapter six gives NMR experiments, conformational search and docking 
calculations of an active adipokinetic hormone from Anopheles gambiae.  The 
structure of the adipokinetic hormone from malaria mosquito and results from 
the docking calculations are presented.  
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Molecular Modelling and Docking for GPCRs 
2.1 Summary 
Since experimental determination of the three dimensional structures of GPCRs has 
proved to be very difficult, molecular modeling has been a very powerful tool in 
designing drugs that target this family of proteins.   Chemical properties of molecules 
are obtained by using quantum and molecular mechanics.   In molecular mechanics, 
homology modelling and molecular dynamics are commonly used to produce good 
quality models of GPCRs that have been used and are currently used in structure-
based drug design.   In conjunction with the models, information from docking 
calculations has opened a way for the production of most used pharmaceuticals that 
target the GPCRs.   In this work, homology modelling, molecular dynamics and 
docking studies have been used to determine and characterise the 3D structure of an 
adipokinetic hormone receptor from the malaria mosquito.   An overview of these 
methods is presented in this chapter.   Details of experimental procedures and 
materials used are given in chapter three to six.  
2.2 Molecular Modelling 
 Molecular modelling gives numerical representations of molecular structures and 
simulates their behaviour with equations of quantum and classical physics [1].   
Therefore, programmes used in molecular modelling generate and present molecular 
data ranging from bond lengths, bond angles, torsion angles, energies, electronic 
properties, volumes, viscosity and spectroscopic properties [1,2].   Thus, the method 
is used to design new materials for which an accurate prediction of physical properties 





methods and molecular mechanics, in molecular modeling, chemical properties of 
molecular structures are studied [2,3,4].   
 Ab initio methods require a long simulation period and a large amount of disk 
space to store intermediate data files, it is limited to compounds with less than twenty 
atoms [1,2,3].   When applied to modelling of large GPCRs molecules, such as D2 
dopamine, β2-adrenergic and 5-HTs serotonin receptors, ab initio methods gave 
results inconsistent with the rhodopsin structure [4].   The helices were predicted to be 
having a clockwise or nonsequential arrangement, whereas Class A receptor helices 
have an anticlockwise and sequential arrangement from helix one to seven [5,6,7,8].  
In contrast, molecular mechanics calculations are fast and efficient, and are 
used to simulate systems containing thousand of atoms [1,2,4].   The method is used 
to compute molecular properties that include geometry, rotational barriers, vibrational 
spectra, heats of formation and the relative stability of conformers [1,2].   Molecular 
mechanics relies on the laws of Newtonian physics and experimentally derived 
parameters to calculate geometry as a function of potential energy based on a force 
field (equation 2.1). 
Epot = ∑Ebnd + ∑Eang  + ∑Etor + ∑Eoop + ∑Evdw + ∑Eel   2.1 
Where Epot = total steric energy 
Ebnd = the energy resulting from deforming a bond length from its natural 
value. 
Eang = the energy due to deformation of an angle from its natural value 
Etor = energy from deforming the torsion or dihedral angle 
Eoop = the out-of-plane bending component of the steric energy 
Evdw = energy arising from van der Waals non-bonded interactions, and  





When simulations based on physical properties of atomic interactions fail due 
to complexity of the system, homology or comparative molecular modelling methods, 
based on a similarity analysis of known structural and chemical data is performed [3].   
These methods have been widely applied in molecular modelling of complex and 
highly flexible GPCRs based on known crystal structures.  
2. 2. 1 Computer Simulation Methods  
Molecular dynamic (MD) and Monte Carlo simulations are the most popular 
computer simulation methods that can be employed in molecular modelling when 
measurements are made on large samples that contain extremely large numbers of 
atoms or molecules [2,3].   The methods enable prediction of their properties using 
techniques that consider small replications of the macroscopic system with 
manageable numbers of atoms or molecules.   During simulation, representative 
configurations are generated in such a way that accurate values of structural and 
thermodynamic properties can be obtained with a feasible amount of computation 
force [2].  
In Monte Carlo simulations, there is no temporal relationship between 
successive configurations and the outcome of each trial depends only upon its 
immediate antecedent [2].   Total energy is determined directly from the potential 
energy and simulations do not require computation forces.  In comparison to MD, the 
simulation method does not yield significant better statistics within a specified 
amount of computer time [3].  
On the other hand, MD simulations predict the configuration of the system at 
any time in the future or at any time in the past and give information about the time 





improper dihedral angles and non-bonded interactions [2,3].   MD has a kinetic 
contribution to the total energy and is performed under conditions of constant number 
of particles (N), volume (V), and energy (E).   The method can be adapted to simulate 
at constant N, pressure (P) and temperature (T), the NPT ensemble.   MD has 
commonly been used in simulations of GPCR models and remains an important tool 
for studying their stability and flexibility in water [9] and for visualisation of 
conformational changes in a membrane [10,11].   
2.2.2 Molecular dynamics simulations 
MD simulations involve the integration of Newton’s equations of motion for a 
number of atoms interacting under the influence of a force (F) (equations 2.2 and 2.3) 
[2,3]. 
             F = ma      2.2 
Where m is mass of an atom and a is acceleration of the atom, 
    d2xi/dt2 = Fxi/mi     2.3 
Where, mi = mass of an atom along one coordinate xi 
                  Fxi = Force on the atom in that direction. 
Integration of the equations of motion yields a trajectory that describes how the 
positions, velocities and accelerations of the atom in the system vary with time [2,3]. 
 
Verlet Algorithm  
The Verlet algorithm [12] is the most widely used method for integrating the equation 
of motion in MD simulations [2].   The method uses the positions (r) and 
accelerations, (a), at time, t, and the positions from the previous step, r(t - δ t), to 





Verlet integration algorithm, equation 2.4, velocities (v) do not appear but can be 
calculated from either equation 2.5 or estimated at half-step (t + ½δt)  (equation 2.6). 
   r( t + δt) = 2r(t) - r(t - δt) + δt2a(t)    2.4 
          v(t) = [r( t + δt) – r(t)]/2 δt    2.5 
   v(t + ½δt) = [r( t + δt) – r(t)]/δt    2.6 
 
Leap-frog algorithms 
The Leap-frog algorithm [13], is a variation of the Verlet algorithm that uses the 
relationships shown in equations 2.7 and 2.8 [2]. 
   r( t + δt) = r(t) + δt v(t + ½δt)     2.7 
   v(t + ½δt) = r( t – ½δt) + δta(t)    2.8 
The velocities at time, t can be calculated from 
   v(t) = ½[v(t + ½δt) + v(t - ½ δt)]    2.9 
There is a ‘leap-frog’ of velocities over the positions to give their value at t + ½δt.   
The positions then leap over the velocities to give their new values at t + δt, ready for 
the velocities at t + 3/2δt, and so on [2,3].   The inclusion of the velocity and lack of 
calculation of the differences in large numbers make the leap-frog algorithm 
advantageous over the Verlet algorithm. However, it has the disadvantage that the 
positions and velocities are not synchronised.   The integration of equations in 
GROMACS is performed by the leap-frog algorithm [3]. 
 
Choice of time step 
The time step used during MD simulations is important and if an inappropriate value 
is used this leads to artefacts [2].   Specifically, with very small time steps the 





results in instability in the integration algorithm due to high energy overlaps between 
atoms [2,3].   The stabilities would lead to a violation of energy and linear momentum 
conservation resulting in a failure because of numerical overflow.   Longer time step 
can be used when the properties of the bonds are constrained to their equilibrium 
values while still allowing the rest of the degrees of freedom to vary under the 
intramolecular and intermolecular forces available [2].  In GROMACS, a timestep of 
1fs or 2fs is normally used [3]. 
 
Periodic boundary conditions 
Periodic boundary conditions (PBC) help to minimise edge effects in a finite system 
[2,3,14].   The conditions are applied by putting the system to be simulated into a 








 Figure 2.1: Periodic boundary conditions in two dimensions [3]. 
 Therefore, the error of the periodic conditions replaces the error caused by unwanted 
boundaries in an isolated cluster.   Hypothetically, any cell shape such as, cube, 
hexagonal prism, the truncated octahedron, the rhombic dodecahedron and the 
elongated dodecahedron, can be used provided it fills all the space by translation 






spherical cell requires fewer solvent particles than a cubic cell [2, 14,15,16].   The 
triclinic unit cell is the most general space-filling unit cell for it comprises all possible 
space-filling shapes [14,16]. 
Simulated Annealing 
To solve the problem of local minimum in predicting the 3D structure of AKHR, 
simulated annealing was used during conformational space search [2,3,17,18].   
Simulated annealing is a process in which the temperature of a system is reduced 
gradually with the aim of obtaining a conformation that would correspond to the 
global minimum of the potential energy [2].   Using Molecular dynamics, the system 
is allowed to reach ‘thermal equilibrium’ at a given temperature.   At high 
temperatures, the molecules can overcome high-energy barriers [2].   As the 
temperature falls gradually, the conformations of low energy become more probable 
according to Boltzmann distribution and at absolute zero, the system should occupy 
the lowest-energy state giving the global minimum energy conformation.   However, 
practically this is difficult to achieve, so a collection of runs is used for the global 
minimum to correspond to the true minimum [2].   
2.3 Molecular modelling of AKHR 
To facilitate drug design using GPCRs, homology (comparative) modelling, and 
molecular dynamics (MD) simulations have been increasingly successful in predicting 
the 3D structures of this important protein family[19,20,21,22].   Almost all known 
drugs that target GPCRs have been designed from molecular models of their 
receptors, for example, Neuropeptide Y receptors (NPY) [23], CXCR4 [22], 
endothelin receptors [20], opioid receptors [21], beta2-adrenergic receptors [24, 
25,26], gonadotropin releasing hormone (GnRH) receptor [27], tachykinin receptors 





Recently, molecular models have been successfully used in characterisations of insect 
peptide GPCRs like pheromone biosynthesis activating neuropeptide (PBAN) 
receptors [31,32].    
In this thesis, homology modelling was used to build the 7TMs of AKHR. For 
optimisation of the loops and the whole AKHR molecule, MD simulations were 
performed in vacuum, water and membrane using the Groningen Machine for 
Chemical Simulation (GROMACS) software package [3] available at 
http//www.gromacs.org.  
2.3.1 Homology Modelling of 7TMs  
Homology modelling produces an atomic resolution model of a protein from its amino 
acid sequence (target), based on its alignment to one or more related known protein 
structures (templates) [33,34].   The success of homology modelling is largely 
dependent on the evolutionary relationship between the target and the template 
proteins.   It has been shown that GPCR homology models are accurate enough to 
identify known antagonists seeded in any ‘drug-like’ library [34,35].  
 Before 2007, the only available templates for building 3D models of 
structurally diverse GPCRs, were the crystal structures of rhodopsin [5,36,37].   
Rhodopsin is homologous to most GPCRs and its helices have an anticlockwise 
arrangement [5].   The arrangement of helices of Class A receptors was previously 
evidenced by application of protein engineering [38,39] and confirmed by the crystal 
structures of rhodopsin [5,36,37].   Therefore, most GPCR models have been 
constructed with the 7TMs in an anticlockwise arrangement when viewed from the 





[41], provided an alternative templates that could be used in homology modeling of 
Class A GPCRs for diffusible ligands such as AKH [42].   
In this work, the recently published primary sequence of AKHR [43,44] was 
used to build the 3D structure of the receptor.   Since the helical region is the core of 
GPCRs and plays an important role in ligand binding and receptor activation, 
homology modelling was applied to model the transmembrane region of AKHR, 
using crystal structures of both rhodopsin and β 2AR receptor as templates [4-
6,19,23,36,40,41,45].   To predict the helical regions, programmes such as PSIPRED 
and the MEMSAT3 [46,47] were used.  
2.3.1.1 Homology modelling protocol 
The first step in homology modelling involves identifying templates whose sequence 
is closely related to the sequence of the target, from the PDB [2,33,34,35].   Choice of 
template is important given that models produced are usually more similar to the 
template used rather than the native structure of the sequence of interest [19].   Since 
AKHR belongs to the same receptor family as rhodopsin and β2AR, both crystal 
structures were used as templates for building its 7TMs.   
Secondly, pairwise sequence alignments of the target sequence and the 
template is performed using programmes such as the Swiss –Model workshop [34,35] 
and ClustalW available on http://www2.edi.ac.uk/clustalW [48].   Sequence alignment 
identifies and computes the matches between template and target and is the most 
crucial step in homology modelling [2,19,49].   In the case of GPCRs, the highly 
conserved residues found in the core of the receptors are matched.   Percent sequence 
identities and similarities between the target and the templates can be calculated by 





the shorter sequence [47,49,50].   Accuracy of homology modelling is related to the 
percent sequence identity [33], with 50% sequence identity of target to template 
giving highly accurate models, 30-50% producing medium accuracy and low 
comparable models are obtained from < 30% identity.   However, it has been shown 
that proteins with similar sequences tend to have similar 3D structures [2].   In 
general, GPCRs have below 40% sequence identity with their templates, so modelling 
of the 7TMs is based on the high percent sequence similarity and the similar 3D 
structure of this domain [2,45].     
Having obtained an acceptable sequence alignment, the known 3D structure 
and the alignment are used to build the model using tools like, MODELLER [51], 
WHATIF [52] and Swiss-Model workshop [34].   The final stage involves analysis of 
the model by considering, for example, the Ramachandran plots for psi and phi angles 
of each residue [3,55,56,57], in order to determine whether the amino acid residues 
occupy energetically favourable regions [2].   Where available the results are 
compared with experimental results.  
 2.3.2 MD simulations of AKHR  
As with most GPCR models, the loop regions of AKHR were built separately, joined 
to their respective helices and then optimised by performing molecular dynamic (MD) 
simulations [23,20,56,57].   To search for membrane associated conformations of the 
free and unbound AKHR molecules MD simulation was performed in a membrane 
model.  
2.3.2.1 MD simulation protocol 
To set up and run MD simulation, firstly, the initial configuration for the system 





combination of the two [1,2,3].   The configuration chosen should be close to the state 
that it is desired to simulate.    A description of the force field for the system is given 
in the topology file [3].   A variety of force fields such as the GROMACS, GROMOS 
and OPLS/AA [3] could be applied in GROMACS.  The OPLS/AA all atom-force 
field that includes the amino acid dihedrals [58], was used in molecular dynamic 
simulations of AKHR.   The force could include contributions of the various terms in 
the force filed such as bonds, angles, torsion and non-bonded interactions.    
 The potential functions used in most force fields are divided into non-bonded, 
bonded interactions and restraints [3].   The non-bonded (the Lennard-Jones and 
Coulomb) interactions are computed based on a neighbor list in which exclusions are 
already removed [3].   On the otherhand, the bonded interactions (covalent bond-
stretching, angle-bending, improper and proper dihedrals) and restraints such as 
(position, angle distance and orientation restraints) are calculated based on fixed lists.   
Initial velocities are assigned to the atoms by random selection from a Maxwell-
Boltzmann distribution at a temperature of interest [2,3].   The initial velocities are 
adjusted so that the total momentum of the system was zero.   Differentiation of the 
potential function calculated the force acting on each atom at each step during the 
simulation.    
 Secondly, energy minimization of the system is performed to ensure that the 
initial configuration did not contain high-energy interactions as these may cause 
instabilities [2,3].   In GROMACS, this is achieved by using the steepest descent, 
conjugate gradients or the limited-memory Broyden-Fletcher-Goldfarb-Shanno (l-
BFGS) algorithms [3].   Steepest descent is robust and easy to implement whilst 
conjugate gradient is slower in the beginning of minimization but becomes more 





convergs faster and was used in most energy minimizations of AKHR.    
 Thirdly, the system is equilibrated to enable it to evolve from the initial 
configuration to reach equilibrium [2,3].   During these stages thermodynamic and 
structural properties like kinetic, potential and total energies, velocities, temperatures 
and pressure, are monitored until stability is achieved. 
 The production stage involves calculation of simple properties of the system 
[2,3].   For this stage molecular dynamics parameter file containing all parameters to 
be used during dynamics are the input file [3] and at regular intervals, the atomic 
coordinates of the system are recorded.   To include knowledge from experimental 
data and for imposing restraints on the motion of the system, distance and position 
restraints were used in MD simulation of AKHR [3].  
Position restraints  
Position restraints are used to restrain particles to fixed reference positions, Ri.   The 
solvent and any counter ions are allowed to evolve whilst the protein atoms remained 
at fixed positions, [2,3].   Position restrained MD should be sufficient to allow the 
solvent to completely readjust to the potential of the solute and soak the protein.  The 
length of this solvent equilibration stage should be longer than the relaxation time of 
the solvent, for example, 10ps for water [2,3].   In GROMACS, position restraint 
potential (Vpr ) is calculated from equation 2.9.  
    Vpr (ri ) = 1/2 kpr |ri −Ri |2      2.9 
Distance restraints 
Distance restraints add a penalty to the potential when the distance between specified 
pairs of atoms exceeds a threshold value [3].   The restraints are used to impose 
experimental restraints, as from nuclear magnetic resonance (NMR) experiments, on 






refinement using NMR data [3] and measured interhelical distances.   The potential 
form for distance restraints is normally quadratic below a specified lower bound and 
between two specified upper bounds and linear beyond the largest bound [3] as shown 
in figure 2.2.  
   
 
 
                                                                                                                                                                                                                                                                         
 
   
Figure 2.2: Distance restraints potentials [3] 
2.3.2.2 MD simulations of AKHR in a membrane 
GPCRs exhibit very complex and dynamic structural properties due to their high 
flexibility [10].   Vacuum MD simulations of most models of GPCRs have generated 
models currently used in drug design but this does not represent the true environment 
of the receptor.   To represent the physiological conditions of these GPCRs, a number 
of membrane-embedded human GPCRs models have recently been published 
[10,11,59-61].   Phospholipid bilayers represent the fundamental structures of most 
biomembranes [62].   Periodic lipid bilayers consisting of, for example, 1-palmitoyl-
2-oleoyl-sn-glcero-3-phosphocholine (POPC) and dipalmitoyl phosphatidyl choline 
molecules (DPPC), solvated with water, have been simulated and equilibrated [59]. 
POPC and DPPC are commonly used in MD simulation of GPCRs [61].   To that 
effect, MD simulations of both free and bound AKHR embedded in a pre-equilibrated 






2.3.2.3 Analysis of the MD simulation trajectory 
In this thesis, analysis of the trajectory obtained from simulations of the protein, using 
tools set in GROMACS software package [3] was the last stage.   These included 
cluster analysis to find similar conformation within a given root mean square 
deviation [2].   From the most popular cluster, the lowest energy conformation gave 
the final structure of the molecule.   The root mean square deviations (rmsd), root 
mean square fluctuations (rmsf), radius of gyration (rg), secondary structure analysis 
[3,9-11,63] were applied to determine the stability, structural and conformational 
changes of the receptor molecules.   Molecular visualisation was carried out using 
PYMOL [64], MOLMOL [65], VMD [66] and PMV [67]. 
Root mean square deviation 
The root mean square deviation of the backbone atoms (N, Ca, C) in a molecule with 
respect to a reference structure, e. g. the initial structure or the crystal structure, was 
calculated by the least-square fitting of the backbone atom positions to the reference  
molecule [3,9].   Subsequent calculation of rmsd was performed using the equation 
2.10,  
                                 N                                                                                                  
   RMSD(t1,t2)=[1/M∑mi||ri(t1)-ri||2]1/2                                                            2.10 
           i=1 
Where M is the sum of the masses of the atoms, mi, and ri(t) is the position of the 
atomi at time t. 
Root mean square fluctuation 
The root mean square fluctuations (rmsf), is the standard deviation of the Ca atoms of 
the protein during simulations, after fitting to the initial structure [3].   Rmsf values 






Radius of gyration 
The radius of gyration (Rg) is a measure of the compactness of the molecule during 
simulation [3,68,69] and is calculated as follows, 
   
     Rg = (∑i||ri||2mi/∑imi)1/2 
 
Where mi is the mass of the atom, i and ri the position of the atom with respect to the 
centre of mass of the molecule. 
Secondary structure analysis 
To look at the structural changes during dynamics, the programme DSSP [70] is used 
to determine the secondary structure variations of each residue.   The DSSP 
programme analyses the secondary structure of the protein by a pattern-recognition 
process of hydrogen-bonding patterns and geometrical features extracted from atomic 
coordinates. [3,70].   For each residue, secondary structure variations are plotted 















2.4 Molecular Docking  
In the absence of a crystal structure of ligand/receptor complexes, molecular docking 
is used to provide information on the position, interactions and preferred interactions 
between ligands and their receptors [71].   Molecular docking methods place (dock) a 
ligand in the binding pocket of a receptor [71-73] and therefore the structure of the 
ligand/receptor complex and binding modes are predicted [2].   Structural information 
obtained proved to be very important to the Medicinal Chemist and has been 
developed to implement structure-based drug design [2,71-74].   Since the 3D 
structures of most GPCRs are not known, their molecular models are used in 
molecular docking leading to identification of a variety of ligands currently used in 
pharmaceutical industry [20-22,75-77].   Therefore, application of molecular docking 
to adipokinetic hormone receptor model could lead to identification of ligands with a 
high affinity for the receptor.  These compounds can be used in the production of 
agonist and antagonists with high specificity for the protein that could block its 
binding pocket and hinder generation of energy during mosquito flight. 
 Several docking methods have been developed and these differ mainly in how 
they position the ligand, explore conformational space, represent ligand/receptor 
interactions and in scoring (binding affinity estimation) methods [71,78-80].  The first 
group of algorithms included DOCK [81,82], FTDOCK [83], QSDOCK [84], FlexX 
[85,86] which try to fit the ligand into the binding pocket by geometrically, 
chemically and energetically matching [79].  On the other hand, GOLD [87,88], 
DARWIN [89] and AUTODOCK [90] apply genetic algorithms to search for the 
global minimum of the energy in the continous conformational space of the ligand 





2.4.1 Docking protocol 
Docking procedures involve firstly, identification of the binding site in a target 
molecule.   For previously defined binding sites the search space is restricted to a 
relatively small part of the protein.   When no information on the binding site is 
available, putative sites could be identified by cavity detection programmes [91,92] 
and blind docking [93].   Blind docking allows the ligand to scan the protein surface 
to identify accessible cavities.   By using Autodock, blind docking was successfully 
perfomed to identify binding pockets of a variety of proteins [93-97].    
Secondly, docking calculations involve choosing the most suitable search 
algorithm that effectively samples the set of possible ligand positions and 
conformations on the protein molecule [78,79].    A good algorithm should be able to 
sample regions of the search space close to the correct solution without a complete 
search of all conformations and orientations [78].    Random search involved 
generation of a large set of random ligand positions and conformations and the 
ligands are ranked with a suitable scoring function.  The algorithm was mainly used 
as a starting point for other algorithms [78].   Rigid body docking involved rigid 
ligand and protein molecules and is commonly used in DOCK [81], FTDOCK [82] 
and QSDOCK [84] methods.   The third search algorithm is simulated annealing 
which is based on a model of systematic reduction of temperature [98,99], which was 
commonly used by first versions of Autodock [78].   GOLD [87], Autodock [90] and 
DARWIN [89] are examples of docking methods that applied genetic algorithms 
when searching for the position and conformations of the ligand [78].  In genetic 
algorithms, a population of solutions undergoes mutation and higher order 
transfomations.  The generated solutions experience selection biased towards the most 





 The third and last component of docking procedures is scoring that estimates 
the binding free energy (ΔGb) for the ligand when bound to the receptor [2].   The 
more negative the ΔGb, the stronger the intractions between the ligand and the 
receptor and the higher the binding affinity.    Simulation techniques used considered 
that ΔGb was written as an additive equation of various components to reflect the 
various contributions to binding (equation 2.12) [2].   
  ΔGb  =  ΔGsolv   + ΔGconf  + ΔGint  + ΔGrot  + ΔGt/r  + ΔGvib           2.12 
Where ΔGsolv is the contribution of the solvent due to solvent effects, 
 ΔGconf is from the conformational changes in the protein and the ligand, 
 ΔGint is the free energy due to specific protein-ligand interactions, 
 ΔGrot is the free energy loss associated with freezing internal rotations of the 
 ligand and the protein,     
 ΔGt/r is the loss in translational and rotational free energy caused by 
association of two bodies to give the bound complex, 
 ΔGvib is the free enrgy changes due to vibrational modes. 
In addition to identifying the ‘true’ docking mode of ligands the scoring functions 
should also be able to rank the ligands [2,78].   
2.4.2 Molecular docking of AKHR 
Since Autodock has been successfully used in blind docking of  ligands to receptors 
whose binding sites were unknown [93,96,97], Autodock4 and Autogrid4 [90] were 
used to identify the binding site of AKHR and the binding modes of two active 
adipokinetic hormones, anoga_akh from Anopheles gambiae and Del_CC from the 





 Autodock uses a hybrid of genetic algorithm, the Lamarckian genetic 
algorithm (LGA), to search for conformational space of the ligand [78,79,90].   The 
ligand’s state is given as a chromosome with strings of real-valued genes describing 
its position, orientation and conformation [78,79,90].   Placement of the ligand begins 
by creating a random population of individuals, then specifying a number of 
generation cycles.   Each generation cycle is followed by local search and the 
solutions are scored using the energy-based scoring function [79,90].   This includes 
terms accounting for short-range van der Waals and electrostatic interactions, loss of 
entropy upon ligand binding, hydrogen bonding and solvation [78,79,90]. 
 Identifying the binding pocket and binding of a ligand to a receptor is dynamic 
with both ligand and protein changing conformation to maximise total free energy 
during free association [71,101].   However, practically this is not easily achieved, so 
docking calculations are carried out with rigid protein molecules [2,71,78,79].   To 
further refine the docking calculations, in this thesis, MD simulations of 
AKHR/ligand complexes were performed with both ligand and protein flexible.    
To circumvent the slow estimation of ΔGb for large and flexible bioactive 
ligands like AKHs, Hetenyi et al, 2006 [102] designed a fast and accurate calculation 
method for binding affinities of such ligands.   The method makes use of an ensemble 
of structures produced by MD simulation and a modified scoring function of 
Autodock 3.0 [90].   Scoring is an important stage in drug discovery for it helps with 
identification of the conformation of the ligand closest to the true structure and 
binding affinities of the ligand to its target [103,104].   Therefore, to efficiently 
calculate the binding affinities and determine the binding modes of AKHs to AKHR, 
in this work, the improved, fast scoring protocol described by Hetenyi, 2006 [102] 





affinity non-peptides that block the binding pocket of the mosquito adipokinetic 
hormone receptor and thus lead to production of effective insecticides that would 
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Building the 3D structure of AKHR: Homology modelling and 
Molecular Dynamics 
3.1 Summary 
To facilitate structure based drug design using insect GPCRs, the recently published 
primary sequence of AKHR was used to determine its 3D structure.   Homology 
modelling [1], which produces an all atom model of a sequence, was used to build the 
transmembrane helices based on their alignments to the helix bundles in rhodopsin 
and beta2-adrenergic receptor (β2AR).    Rhodopsin has successfully been used as a 
template for most GPCR models but it has a closed structure that protects its ligand.  
The recently published beta2-adrenergic receptor has an open structure, which allows 
ligands to diffuse in and out of the binding pocket [2,3]. 
The loops in AKHR are long and flexible so molecular dynamics (MD) 
simulations were used to determine their conformations [4,5] while tethered to their 
respective helices.    By joining each loop to the helices, two 3D structures of AKHR 
were built.   The resulting molecule was energy minimised and MD simulations, in 
vacuum, performed to optimise the loops.   Movement of the helices was restrained so 
that the general conformations of the helix bundles were maintained.   The minimum 
energy conformation of each molecule gave the final, vacuum, 3D structures of 
AKHR.   These will be referred to as the β2AR-based and the rhodopsin-based 
structures.   Although the two models have similar overall structure, they differ in, for 
example, the conformation of the helix bundle, helical lengths, interhelical distances 





A comparison of the two structures should help in determining the most 
suitable model for use in docking experiments. 
3.2 Experimental Methods  
3.2.1 Modelling the α-Helices 
3.2.1.1 Prediction of secondary structure and transmembrane regions  
The primary sequence of AKHR, (Genbank database accession number AY298745), 
was used to determine the 3D structure of the receptor.   PSIPRED and the 
MEMSAT3 programmes available on http://globin.bio.warwick.ac.uk/psipred/, 
predicted the secondary structure and the transmembrane regions of the receptor.   
PSIPRED makes use of two feed-forward neural networks, which perform analysis on 
output obtained from PSI_BLAST [6] and has shown to be capable of achieving an 
average score of 76.5%.   MEMSAT3 uses neural networks to determine reliable 
topogenic scores from the evolutionary information in the PSI-BLAST- derived 
sequence profiles [7].   Based on the prediction results, the primary sequence of 
AKHR was divided into 7TMs, six loops, N-terminus and C-terminus segments.    
3.2.1.2 Sequence Alignment and homology modelling 
AKHR belongs to the same Class A GPCR family as rhodopsin and beta2-adrenergic 
receptor and has the highly conserved residues commonly found in the helices of 
proteins in this family.   Therefore the crystal structures of rhodopsin, (1F88A) and 
beta2-adrenergic receptor, (2RH1A) from the Protein Data Bank [8] were used as 
templates for homology modelling of its helix bundles.   Pairwise sequence 
alignments of the AKHR helix residues with those extracted from the templates PDB 
files were performed using ClustalW available on http://www2.ebi.ac.uk/clustalW.   





included on both ends of each helix.   The BLOSUM scoring matrix was used for the 
alignments, with the gap penalty set at 10 and the penalty for extending a gap and 
separation of a gap set at 0.05.   The alignments were manually adjusted to remove 
gaps from the helix regions.   Percent sequence identities and similarities between our 
receptor and the templates were calculated by dividing the total number of 
identical/similar residues by the number of residues in the shorter sequence.    
Upon obtaining an acceptable alignment, homology modelling of the 7TMs 
was carried out using Modeller 9 version 3.   Modeller implements comparative 
protein structure modeling by satisfying of spatial restraint [9].   This gives the 
rhodopsin-based and the β2AR-based helical bundles of AKHR.  
3.2.2 Modelling loops, N- and C-terminus 
The loops, N- and C-termini were built separately using InsightII 2005.  
Conformational search for each segment was performed by subjecting them to 
molecular dynamic simulations using GROMACS version 3.3 [10].   All simulations 
were performed at a time step of 2 fs, using the OPLS-AA/L all – atom [11] force 
field and constant temperature, volume and number of particles (NVT).   A cut-off 
1.0nm was used for van der Waals interactions and electrostatic interactions for real 
space calculations.    
3.2.2.1 Molecular dynamics simulations 
In vacuum 
Each loop was put into a simulation box and energy minimised using the low–
memory BFGS minimiser for 500 steps to remove bad contacts.  For each loop, the 
terminal residues were distance restrained to the interhelical distances of their 





position restrained at the interhelical distances and a further 10ns MD simulation was 
performed at 600K.   Since only one starting structure was used, conformational 
search was at high temperature so that the molecule could overcome energy barriers 
[12].   During the production stage, 100 structures collected during the 10 ns high 
temperature simulation, were subjected to 0.1ns simulated annealing to 300K.   The 
loops were energy minimised and cluster analysis performed with a cut-off distance of 
<0.2.     
In water 
The minimum energy conformation from the simulations in vacuum was used as the 
initial structure of the loop for 10ns MD simulations in water.   The system was 
solvated with SPC water.   A force constant of 1000 kJmol-1nm-2 was used during 
position-restrained simulations for 0.1 ns to equilibrate the system and allow the water 
to soak the protein.   All simulations were performed with periodic boundary 
conditions.   The protein and solvent were coupled separately using the Berendsen 
coupling method to a temperature of 300K using a coupling constant, tau (τ)_t, of 1 x 
10-4 ns. 
  The anchor residues were distance restrained to their respective interhelical 
distances during 0.1ns MD simulations.   In the data collection stage, 100 structures 
were collected for analysis during 10 ns molecular dynamic simulations.   Cluster 
analysis of the structures was performed based on a cut-off value of <0.2 nm for 
superimposing backbone atoms.   The minimum energy conformation was identified 
from the largest cluster and used as a starting structure of the loop.   The process was 
repeated for all loops, N-terminus and C-terminus. 
3.2.3 Constructing the 3D structure of AKHR 





based and rhodopsin based AKHR helical bundles.   The protein molecules obtained 
were energy minimised and subjected to 10ns MD simulations in vacuum to relax and 
optimise loops.   The helices were fixed to maintain their conformation and allow free 
movement of the loops.   The minimum energy structures, from a 10ns MD 
simulation, gave two models of AKHR.   The models were viewed and analysed using 
the programs PYMOL [13] and MolMol [14].  
3.3 Results and Discussion 
The recently published primary sequence [15,16] of the adipokinetic hormone 
receptor (AKHR), (Genbank database accession number AY298745), from the 
malaria mosquito, Anopheles gambiae, was used to predict and model its 3D 
structure.   Secondary structure and transmembrane region predictions of AKHR, by 
the PSIPRED programme and the MEMSAT3 programs [6,7], indicate that 218 













Figure 3.1: Predicted Secondary structure of AKHR.  Pred: Predicted secondary 






seven transmembrane helices, black gives residues in loops, N- and C- termini and green 
shows the highly conserved residues. 
 
These helices consist of the highly conserved residues and patterns commonly found 
in Class A GPCRs [1,17,18], namely, N in helix 1, D in helix 2, D/ERY in helix 3, 
CWTPY in helix 6 and NPVVY in helix 7.  
Sequence alignments of the transmembrane residues of AKHR with those of 
beta2-adrenergic receptor (β2AR) [19] (Protein Data Bank (PDB) identity 2RH1A, 
Appendix B) and rhodopsin [2] (PDB identity 1F88A), in Appendix B and C showed 
relatively low sequence identity but high sequence similarity (Table 3.1).   The low 
percent sequence identity values between AKHR helices and the two templates are 
typical of GPCR superfamily proteins.   These proteins are known to have low 
sequence identity but similar structural and functional features due to high sequence 
similarity [20].   















(%) identity with 
 
 β2AR        rhodopsin 
Percent sequence (%) 
similarity with 
 
 β2AR                rhodopsin                                   
1  14                      23  54                             50 
2  25                      14  58                             52 
3  29                      30  68                             60 
4  28                      40  76                             80 
5  23                      17  65                             60 
6  34                      23  83                             74 






The helix segments in AKHR have high sequence similarity with both 
rhodopsin and β2AR indicating a high structural similarity between them [21].   The 
alignments were used to build two homology models of the 7TM bundles of AKHR 








Figure 3.2: The seven transmembrane helices of adipokinetic hormone receptor.   a) 
β2AR-based seven transmembrane helices of AKHR and b) Rhodopsin-based seven 
transmembrane helices of AKHR.   The two helical bundles have the same overall 
structure and an anticlockwise arrangement of helices. Helix3 (H3) is tilted and helix 
4 (H4) is the shortest.   The bundles have the eighth intracellular helix that is parallel 
to the cell membrane. 
 
Accurate loop modelling determines the usefulness of a protein model in recognising 
ligand-binding sites and for ligand docking experiments [22].    The N-terminus, 
extracellular loops (ECL), intracellular loops (ICL) and the C-terminus in AKHR are 
longer and more flexible than those in both β2AR and rhodopsin.   Therefore, 
molecular dynamics (MD) simulations were used to search conformational space for 
each structural domain.   Cluster analysis and an overlay of the 100 structures 
obtained from a 10ns MD simulation in water, showed that each loop has a strongly 














Figure 3.3: Cluster of 100 structures from MD simulation of the second extracellular 
loop. 
 
The conformation of minimum energy of each loop was added to the two 3D 
structures of the helices to give starting structures for molecular dynamics of the 
complete receptor.    
The cysteine – cysteine disulphide bond between the second extracellular loop 
(ECL2) and helix 3, which plays an important role in receptor stability and function, 
has been found in ~90% of the identified Class A GPCRs [23,24].   In this receptor, 
Cys121 at the extracellular end of helix 3 and Cys197 in ECL2 have a high 
probability of forming a disulphide bond.   A disulphide bond between Cys121 at the 
extracellular end of helix 3 and Cys197 in ECL2 was therefore built.   A further 10ns 
MD simulation of the complete receptor to optimise the loops gave two 3D structures 

















  (a)         (b) 
Figure 3.4:  a) The β2AR-based structure and b) the rhodopsin-based structure.   In the 
extracellular region (region outside the cell) of the β2AR-based AKHR, there are β -
strands in the ECL1 and the N-terminus, and a helix in the N-terminus, not found in the 
rhodopsin-based structure.   Both molecules have the eighth intracellular (inside the 
cell) helix at right angles to the helical bundle. 
Ramchandran plots [25,26,27] of the two structures show that, 89% of residues in 
β2AR-based AKHR and 86% of residues in rhodopsin based AKHR have psi (ψ) and 
phi (Φ) angles in favoured regions (Figure 3.5), indicating that the models are of 
acceptable quality.    Most residues in the disallowed region are found in the ECL and 
the ICL regions and residues in the helix bundle are found in the highly favoured 















    
Figure 3.5:   Ramchandran plots of psi (ψ) and phi (Φ) angles of residues in a) the 
β2AR-based and b) rhodopsin-based 3D structures of AKHR.   The highly favoured, 
favoured, least favoured and disallowed regions for values of ψ  and Φ angles are 
indicated as green, yellow, pink and white respectively.   Each blue dot represents a 
residue and the blue cross represents glycine.  About 89% and 86% of residues in open 
AKHR and closed AKHR, respectively, have ψ and Φ angles in the favoured regions. 
 
3.3.1 Analysis of the helix bundles 
The rhodopsin and β 2AR-based 3D structures of AKHR have similar overall 
structures.   When viewed from the extracellular region, the AKHR helix bundles 
have an anticlockwise arrangement of the 7TMs from helix 1 to helix 7 and a tilted 
helix 3, which is common in all Class A members of the GPCR family [2,7].   The 
anticlockwise arrangement of helices in GPCRs is supported by the distance 
constraints from the engineered Zinc (II) binding sites in neurokinin 1 (NK-1) 






The seven transmembrane helices are stabilized by interhelical interactions 
involving the highly conserved residues [17].   Class A GPCRs contain a conserved 
aspartic acid in helix 2 (AspII.10 according to the Schwartz numbering scheme [30]) 
and an asparagines in helix 7 (AsnVII.16), involved in intramolecular interactions due 
to the close proximity of the two helices [30].   In contrast, in AKHR, helix 2 has the 
aspartic acid, Asp94 (AspII.11) and Asn319 (Asn VII.12) in helix 7 at different 
positions and with their side chains orientated away from each other.   This reduces 
the chances of interactions between them in both the β2AR-based and the rhodopsin-
based structures.   Instead, in the β2AR structure Asn94 forms a salt-bridge with 
Ser135 in helix 3.   Although these residues are both orientated towards the centre of 
the helix bundle in the rhodopsin-based structure, the distance between them, 0.42 
nm, hinders any intramolecular interactions.   However, helix 2 and helix 7 interact 
through formation of a H-bond between Asn84 and Tyr324 found in the highly 
conserved NPxxY motif of helix 7.   There is also a polar interaction between Asn65 
(helix 1) and Ser317 (helix 7) which help in stabilising the structure.   These 
interactions involving helices 1, 2 and 7 are structurally important for all Class A 
GPCRs [ 31]. 
Experimental work supports the presence of kinks that cause helices to twist 
(bend) [32].   The helices in the two AKHR models have proline-induced kinks and 
bends [33] at approximately the same positions.   Where Met, Thr or Tyr precedes the 
proline, the kinks result in the formation of a bend or a turn, viz helix 2 at Met101-
Met102, helix 5 at Tyr221-Thr222, and helix 7 at Thr314.   In helix 6 the kink causes 
a twist towards helix 5 in the extracellular region.   It was observed that although 





4-3 residues.   Evidence of the helices extending two to three turns in GPCRs, was 
provided by studying the accessibility of attached nitroxide labels to collisions with 
paramagnetic probes in solution in the third intracellular loop that joins helices 5 and 
6 during electromagnetic spectroscopy of rhodopsin [34].   In general, both models 
have shorter helices than their respective templates, 179 residues in the β2AR-based 
model and 174 residues in the rhodopsin-based model compared to 204 and 194 
residues in β2AR [19] and rhodopsin respectively [35].   
An overlay of the two 3D structures gave a root mean square deviation (rmsd) 
of 0.79 nm, for the optimal superimposition of C- alpha (Cα) atoms [36] of the whole 
molecule and 0.45 nm for the helix bundles.   Although the overall structures are 
similar, the two have different structural features that cannot be ignored.   The β2AR-








Figure 3.6: Side view of an overlay of helices of β2AR-based (orange) and rhodopsin-






helices 1-7 (H1-7) and in the extracellular region, β 2AR-based AKHR helices are 
drawn away from the centre of the helix bundle.   This gives it an open conformation 
compared to the conformation in the rhodopsin-based AKHR. 
 
Longer interhelical distances and an outward deflection of helices 1, 3, 4 and 6 away 
from the centre of the helical bundle in β2AR evidence the open conformation.   The 
angle of deflection between helix 1 in the β2AR and rhodopsin based AKHRs is 44 + 
0.25o and the distance between the ends of the helices is 10 + 0.20 Ǻ (Figure 3.7a).   
The rhodopsin based AKHR has a closed conformation as in the crystal structure of 
rhodopsin.   A closed conformation in rhodopsin protects the covalently bound cis-
retinal from hydrolysis [19].   Since binding of peptide hormones often involves the 
transmembrane domain and the amino terminus [29], the closed conformation would 








Figure 3.7: Comparisons between helices in the AKHR models 
A) The deflection of helix 1 (H1) in β2AR-based AKHR (orange) from helix 1 (H1) in 
rhodopsin-based AKHR (blue).   The distance between the Cα atoms of Histidine at the 
extracellular ends of the helices is 1 + 0.2 nm and angle of deflection is 44 + 0.25o.   
Different arrangements of the side chains of the helix residues result in different 
interhelical interaction. B) There is no ionic interaction between the highly conserved 
Arg146 at the intracellular end of helix 3 (H3) and residues in helix 6 (H6) of β2AR-
based AKHR. C) An ionic interaction (broken line in red) exists between Arg146 in H3 






In the β2AR-based structure, the distance between these residues (1.7 nm) is too large 
for the two to interact. 
 
Rhodopsin and β2AR yield models in which the same residues occupy different 
positions in the helical bundle.   The side chains of these residues have different 
orientations, resulting in different interhelical interactions.   This structural difference 
is clearly shown around the highly conserved DRY sequence at the cytoplasmic end 
of helix 3 [3].   In the β2AR-based AKHR there is no ionic interaction involving the 
positively charged side chain nitrogen atom of Arg146 in helix 3 and the backbone 
C=O of Lys262 in helix 6, which has a distance of 1.7 nm between them (Figure 
3.7b).   This open structure is therefore very flexible with high agonist-independent 
activity inside the cell (basal activity).   Instead, Arg146 forms a salt bridge with 
Ile142 in helix 3.   To stabilise the molecule, helices 5 and 6 form salt bridges in the 
intracellular side, involving Ser241, Arg242, Tyr236 in helix 5 and Lys265, Arg268 
in helix 6.   Dror R. O et al (2009), found that the inactive β2AR exists in equilibrium 
between conformations with the ionic lock ‘on and off’ [37].   This could be the case 
with the β 2AR-based AKHR structure, which does not have the ionic lock between 
helices 3 and 6 but between helices 5 and 6.   In contrast, the rhodopsin based AKHR 
has an ionic interaction between Arg146 and Lys263, since they are 0.29 nm apart 
(Figure 3.7c).   These intramolecular interactions reduce conformation flexibility, 
basal activity and play an important role in receptor activation [30].  
3.3.2 Analysis of the loop regions 
The open and closed conformations of the 7TMs result in different conformations and 
structural features in the extracellular and intracellular domains.   In the closed 





helices covering all potential binding pockets (Figure 3.2).   There are neither beta (β) 
sheets nor helices in the loop regions except for a small-predicted helical turn from 
Asn3–Met5 in the N-terminus.    
In contrast, the open structure has extracellular loops drawn away from the 
centre of the helical bundle.   ECL1 has a β -strand (Trp114-Gly117), which is not 
found in the rhodopsin-based structure.   The N-terminus does not form a cap over the 
helices. A β-strand involving Tyr24 and Tyr25, and a small helical turn from Glu32-
Tyr35 keep it in an upright position above the helical bundle (Figure 3.2a).   Although 
the N-terminus of rhodopsin was not used to build the AKHR N-terminus, a similar 
helical turn is in the crystal structure of rhodopsin involving Tyr29-Leu31.   In the 
extracellular side of most GPCRs, the helices and the extracellular domains open up 
to form a cavity that serves as a binding pocket for the ligand [30].   As such, the open 
conformation of the beta2 based structure leaves a deep cavity and hence a potential 
binding pocket is created in the extracellular region between helix 7, helix 1, ECL3 
and the N-terminus.   The potentially N-glycosylated Asn27 in the N-terminus of 
AKHR could play an important role in stability of the receptor and in ligand binding 
[38]. 
The intracellular side of AKHR is tightly packed with the second loop drawn 
away from the helix bundle.   The two models contain the eighth helix which is 
parallel to the membrane surface in most Class A GPCRs and is important in G-
protein binding and activation [30].   Palmitoylation plays an important role in 





eighth helix indicates that the C-terminus of AKHR will be stabilised through 
palmytolation of the residue. 
The third intracellular loop, normally not included in GPCR crystal structure 
determination, contains 20 residues in the β2AR-based model and 24 residues in the 
rhodopsin based model.   The rhodopsin-based structure has a helical turn in this loop 
from Ser250 – Ser 254 that is absent in the β 2AR-based structure.   This structural 
feature was also found in the third intracellular loop of a β2AR model after molecular 
dynamic simulations in a membrane [37].   Since GPCRs are highly flexible, the 
different structural features especially in the extra and intracellular domains of the two 
models could represent features in different conformations during molecular 
dynamics and/or in the active and inactive state of the receptor. 
3.4 Conclusion 
In conclusion, the first open and closed 3D structures of an adipokinetic hormone 
receptor from the malaria mosquito were successfully modelled.   The models display 
structural features and intramolecular interactions similar to those found in other 
Class A GPCRs.   The structural features and the general conformation of our models 
are in agreement with most mutational data and could give an insight into the 3D 
structures of insect GPCRs. They are therefore good starting structures for further 
studies involving the AKH receptor and similar insect GPCRs.   In the following 
chapters, the open and closed AKHR molecules were used in molecular dynamics and 
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Molecular Dynamic Simulations of Adipokinetic Hormone Receptor 
in a Membrane 
4.1 Summary 
GPCRs exhibit very complex and dynamic structural properties due to their 
high flexibility [1].   MD simulations remain an important tool for studying the 
stability and flexibility of proteins in water [2] and for visualisation of conformational 
changes in a membrane [1,3].   Vacuum MD simulations of GPCRs have generated 
models currently used in drug design but this does not represent the true environment 
of the receptor.   To represent the physiological conditions of GPCRs, to date, a 
number of membrane-embedded human GPCRs models have been recently published 
[1,3,4,5,6].   Phospholipid bilayers represent the fundamental structures of most 
biomembranes [7].   Periodic lipid bilayers consisting of, for example, 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC) and dipalmitoyl phosphatidyl choline 
(DPPC) molecules, solvated with water, have been simulated and equilibrated [4].   
POPC and DPPC are commonly used in MD simulation of GPCRs [6]. 
In chapter three, the β2AR-based with an ‘open’ conformation, and the 
rhodopsin-based AKHR with a ‘closed’ conformation in the extracellular region, were 
built.   In this Chapter, the ‘open’ β2AR-based and ‘closed’ rhodopsin-based AKHR 
models were used to study the stability and changes in conformation of the receptor 
molecules during MD simulations in a membrane.   Despite changes in conformation 
of AKHR molecules, it was observed that the overall structure and position of the 
helix bundles were maintained throughout the MD simulations.   Movement of the 





closely packed the lipid molecules were around the protein.   In the β2AR-based 
AKHR the helices moved away from each other and the extracellular side widened to 
give the receptor a more open conformation, whilst the rhodopsin-based structure 
maintained the closed conformation.   The N-terminus and the third intracellular loop, 
which are highly flexible and not usually included in crystal structure determination 
of GPCRs, have well defined structures and maintain stable structural features during 
simulations.  
4.2 Experimental Methods  
4.2.1 Membrane preparation and Insertion of the Protein 
GPCRs are transmembrane receptors and to mimic closely the actual environment of 
the receptor, rhodopsin-based and β2AR-based AKHR models were used as starting 
structures in MD simulations in a membrane.   Teilman’s pre-equilibrated 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) membrane model [8] 
containing 128 lipids molecules and 2460 water molecules from 
http://moose.bio.ucalgary.ca/, was used.   The number of water molecules was 
increased from 2460 to 10241 in the z-direction. The water model used was SPC, 
which behaves well in lipid bilayer/water simulations [9].   The lipid/water system 
was increased by a factor of four (x4) in the xy planes.   Water molecules that 
occupied the lipid region were removed manually using PYMOL [10] (Figure 4.1a).  
The AKHR molecules were inserted into the membrane, and aligned with the 
lipid bilayer so that they had the same co-ordinate space as the lipid, using VMD [11].   
The new protein coordinates were transferred so that they were within the same box 





the program genbox from GROMACS to give two protein/lipid complexes, (Figure 
4.1b), consisting of protein, 438 POPC molecules and 37020 water molecules.     
 
      
  (a)       (b) 
Figure 4.1: (a) POPC (green) membrane box filled with water (red and white sphere). 
(b) AKHR (blue ribbon) inserted in the POPC bilayer (green). For clarity, the water 
molecules are not shown. 
4.2.2 Molecular Dynamics Simulations of AKHR in a Membrane 
Molecular dynamics simulations of each protein/membrane complex were carried out 
using the development version of GROMACS 4.0.4 [12].   Energy minimisation was 
performed for 1000 steps using the low – memory BFGS minimiser.   The system was 
neutralised by replacing eleven water molecules with chloride ions (Cl-).   A force 
constant of 1000 KJmol-1nm-2 was used during position-restrained MD simulations for 
1ns to equilibrate the system and allow the membrane and water to soak the protein.   
MD simulation with fixed helices was performed for 100ns and since the systems 
reached steady a state within 10ns, structures were extracted at 10ns, 15ns and 20ns to 
give three starting protein/membrane systems from both β2AR- and rhodopsin-based 
complexes.   The six structures were separately subjected to 100ns of free MD 







The simulations were carried out with a time step of 2 fs, using the OPLS-AA/L all – 
atom [13] force field and at constant temperature, pressure and number of particles 
(NPT).   A cut-off of 1.15 nm was used for van der Waals interactions and the 
particle–mesh Ewald [14,15] method was used to compute the electrostatic 
interactions using a grid spacing of 0.1 nm and a distance from the coulomb cut-off of 
1.15 nm.   The protein, POPC and solvent/Cl- were coupled separately using the 
Berendsen coupling method to a temperature of 300K using a coupling constant, τT, of 
1 x 10-4 ns.   The pressure coupling constant τ p was 5.0ps and a compressibility of 
0.000045 (1/bar) was used.  Neighbourlists were updated every fifth integration time 
step.   The runs were done on a twelve Intel Xeon cluster, each with eight cores 
running at a clock frequency of 2.33GHz.    
4.3 Results and Discussion 
Six 100ns MD simulations of AKHR in a membrane were performed.   To have an 
insight of the changes in structural features during dynamics of the flexible GPCR, 
changes in conformational and the secondary structure were analysed.   Estimation of 
the stability of the receptor molecules, was performed by finding the time dependence 
of the root mean square deviation (rmsd) from the starting structure, the radius of 
gyration (Rg) and the root mean square fluctuations (rmsf).   These properties have 
been used to give a relative estimate of the stability of proteins in water and in 
membrane [1,2,3,16].  
4.3.1 Molecular Dynamics simulations of β2AR-based AKHR model 
The starting structures, o_akhr10, o_akhr15 and o_akhr20, for the 100ns MD 
simulations, were extracted from a trajectory generated from MD simulation of 





simulations in a membrane, the protein molecules maintained the overall structure and 
an open conformation in the extracellular region.   However, there were significant 
fluctuations in different regions of the three molecules.   Due to the presence of 
interhelical interactions and the disulphide bond between Cys197 and Cys212, the 
helix bundles were fairly rigid while the intra and extracellular loop regions were 
flexible.   Figure 4.2 shows the root mean square fluctuations (rmsf) of the Ca atoms 
of the protein during the three simulations.   Although the results for the different 
simulations are similar, the protein in simulation o_akhr10 has the highest variability 
while the movement of o_akhr20 is more restricted.   This may be due to tighter 












Figure 4.2:  The rms fluctuations of o_akhr10 (red), o_akhr15 (green) and o_akhr20 
(black) as a function of time during the 100ns MD simulations. 
 
In all three simulations, ICL3 (243-264), has the highest fluctuations with an rmsf of 






and C-termini (339-354).   In the N-terminus (1-46), residues 13-25 are much more 
rigid.   This region is stabilised by the formation of a salt bridge between Tyr24 and 
Thr115 and the subsequent formation of β-sheets involving Tyr24-Tyr25 and Trp114-
Thr115 in ECL1.   This is similar to the interactions between the N-terminus and 
ECL2 in rhodopsin that results in the formation of β-sheets in the two domains [17]. 
4.3.1.1 Deviations of molecular structures from initial structures 
Structural and conformational changes of AKHR during the three simulations in a 
membrane account for high deviations of the structures from their initial structures as 
shown by the root mean square deviations (rmsd) in Figure 4.3.   The rmsd of the 
backbone atoms were calculated by least-square fitting of the atom positions of our 
model to the starting structure and subsequently calculating the rmsd according to 
equation 1, 
              N      
  RMSD(t1,t2) = [1/M∑mi||ri(t1)-ri||2]1/2     (1) 
              i=1 







    
   (a)                                                                    (b) 
Figure 4.3: Variation of the rmsd values during 100ns MD simulations. (a) Rmsd for 
AKHR structures initially increased to 0.3–0.4 nm.   There was steady increase 
afterwards and the systems reached steady state after about 50ns for the o_akhr10 
(red) and o_akhr20 (black) and at 70ns for o_akhr15 (green) b) Rmsd for the helix 
bundles only showing that steady state was attained after 30ns. 
 
As indicated by the sudden rise in initial rmsd to ~0.3-0.4nm, there were 
marked changes in the AKHR molecules in all simulations.   Highest deviations were 
observed in akhr20 (black), with initial rmsd of ~0.4 nm and fluctuations from 2-30ns 
and 50-70 ns were mainly due to movements in the extracellular and intracellular 
domains, since the helices reached steady state after 30ns (Figure 4.3b).   There was a 
steady increase in rmsd from ~0.3nm to ~0.44nm for o_akhr10 (red) and o_akhr15 
(green).   In o_akhr10 and o_akhr20 equilibratium was reached after about 50ns but 
o_akhr15 only attained this state after 70ns.   However, the three systems approached 
the same rmsd of ~0.57-0.59nm indicating that the structures accomplished stable 
conformations after 70ns with approximately the same deviations from the starting 







4.3.1.2 Compactness of molecules during MD simulations  
The radius of gyration (Rg) indicates the compactness of the protein structures 
[2,19,20,] during the 100ns MD simulations.   This is shown for o_akhr10, o_akhr15 
and o_akhr20 in Figure 4.4.   Although the initial structures had similar compactness, 
simulation o_akhr20 (black) maintained an average Rg of ~2.46 nm from the start, 
indicating that the protein molecule was tightly packed from the beginning of the 
simulation.   However, the drop in Rg at 48 ns could be due to the formation of β-
sheets in the N-terminus (Tyr24-Tyr25) and the second extracellular loop (Trp114-
Gly117).   Structure o_akhr15 (green) was the least compact with a Rg as high as 
~2.58nm due mainly to pronounced changes from α- helicity to bends and turns in the 
secondary structure of the helices.   In o_akhr10 (red), Rg fluctuated during the first 
50ns, and then there was a 3% decrease to 2.43nm, which was maintained until the 
end of the simulation indicating a very small change in the positions of the atoms, 













Figure 4.4: Radius of gyration (Rg) as a function of time of AKHR molecules, 







In all three AKHR simulations, movement of atoms was mainly along the y-axis and 
least along the plane of the membrane.    
4.3.1.3 Conformation Changes during simulations 
4.3.1.3.1 Conformational Changes in the Helix bundles 
In all three simulations, the extracellular side of the helix bundle, moved outward, as 
illustrated by o_akhr20 helices in Figure 4.5.   Although the overall structure of the 
helix bundle was preserved, an overlay of the helix bundles with those in the vacuum 
structure gave an rmsd of ~3.1 nm.   The movement gave the molecule a more open 
conformation compared to the vacuum structure.   This open conformation, as well as 
the anticlockwise arrangement of the helices, was consistent throughout the 100ns 
simulations.   Experimental results have supported the anticlockwise arrangement in 
GPCRs [21,17], which is also found in the crystal structures of rhodopsin and β2AR 
[22,23].   In support of the similarity between AKHR helical bundles and those in  
β2AR and rhodopsin, it has been revealed that most members of Class A GPCRs share 
a similar folding of the 7TM domain [24,25,26]. 
An ‘open’ extracellular and a ‘closed’ intracellular side of β2AR-based AKHR 
are typical of inactive GPCRs, wherein an extracellular cavity that serves as a binding 
pocket for ligands [27], is formed.   This conformation is found in the recently 
published crystal structures of β2AR that contain the inverse agonist, (-)-carazolol 
[22,28] and the antagonist (-)-timolol [29].   The inverse agonist and the antagonists 
stabilise the receptor in its inactive state [6].   Adipokinetic hormones are large octa- 
to decapeptides [30], therefore opening up of the helix bundle creates enough binding 
space for the diffusible AKH agonist. 
 































Figure 4.5: Extracellular view of an overlay of o_akhr20 helices at 0ns (brown), 20ns 
(blue), 40ns (pink), 60ns (cyan), 80ns (yellow) and 100ns (green) from trajectory.   
There is good agreement in conformation of all helices with a more open 
conformation than starting structure. b) Position of H3 and H6 after MD simulation in 
o_akhr20 (pink) and initial AKHR structure (orange).   There was an inward shift of 
H6 in the intracellular region reducing its distance from H3 from 1.84 nm to 1.60 nm 








As in the β2AR crystal structure, Helix 1 (H1) is inclined to the plane of the 
receptor.   The angle of inclination is greater than in the β2AR crystal structure due to 
the outward divergence of the helix from the starting structure.   The divergence is 
evidenced by the shift of the Cα atom in His47 at the extracellular end of the helix by 
0.6 + 0.02 nm with respect to the vacuum structure.   The helices in the vacuum 
structure have similar inclination to β2AR since the crystal structure was used as a 
template to build the helix bundles. 
Helices 3 and 6 were drawn inwards, reducing the distance between them by 
about 0.2nm in the intracellular region (Figure 4.5b).   There was an alternating 
anticlockwise-clockwise rotation and an inward movement of helix 6 (H6).   Such 
movements are commonly found in inactive states of GPCRs [31] and support the 
idea that β 2AR-based AKHR model represents the inactive conformation of the 
receptor.   The inactive state of rhodopsin is characterised by an ‘ionic lock’ involving 
arginine in the highly conserved DRY motif of H3 and residues in H6 [1,26,32].   MD 
simulations of β 2AR molecule, including the third intracellular loop, have 
demonstrated an on and off formation of the ‘ionic lock’ throughout the simulation 
[1].   However, the long intracellular distance between H3 and H6 in AKHR is not 
favourable for the formation of a salt bridge in the intracellular side.   AKHR could be 
an example of a Class A GPCR that does not have the ‘ionic lock’ between H3 and 
H6 in its inactive state [26].   Alternatively, the length of the simulation, 100ns, could 
be too short for the ‘ionic lock’ to form, but in their simulations of β2AR, Dror, R. O 
et al found an ‘ionic lock’ to form within 30-150 ns [1].   To stabilise the molecule, 
AKHR forms an ‘on and off’ salt bridge between Glu238, in H5, and Lys265, in H6.   
Since the distance between the oxygen atom OE1, in Glu238 and nitrogen atom NZ, 





4.3.1.3.2 Conformational Changes in loop domains 
All loops in the extracellular region were drawn outwards and upwards creating space 
for ligand binding.  The orientation of the second loop is similar to that of β2AR, 
which is kept in an upward position above the helix bundle to allow free movement of 
diffusible ligands [33].  Unlike in β 2AR, the N-terminus in AKHR is ordered and 
maintains an upward position above the helix bundle leaving room for the ligand to 
access the putative binding pocket.   Figure 4.6a gives the ribbon structure of the 
backbone atoms of the N-terminus illustrating the general conformation of the 
domain.   Although this extracellular domain is flexible, it has a well-defined structure 
and a conserved backbone conformation.   Similarly, in the intracellular region, the 
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Figure 4.6: (a) The structural similarities of N-terminus as depicted by the 
superimposed backbone ribbons. The region of highest fluctuations from residue 23-
41 maintains a helical turn in most of the conformations.   b) Superimposition of the 
backbone ribbon of third intracellular loop (ICL3).  The loop is the most flexible part 
of the molecule but has conserved conformation and maintains a helical turn in most 









The MD simulations of β2AR in a membrane, including a modeled ICL3, have also 
shown that the loop has a well-defined structure and its presence lead to a decrease in 
the distance between H3 and H6 resulting in the formation of an ‘ionic lock’ [1].    
This feature is not found in the engineered β2AR crystal structures [22,28] nor in 
β2AR-based, AKHR.   From visual inspection of the trajectory and the secondary 
structure analysis, the N-terminus and ICL3 both contain a helix for the greater part of 
the simulation, which is also found in the ordered N-terminus of rhodopsin and the 
modeled ICL3 in β2AR [1].   The second intracellular loop was drawn away from the 
helix bundle in such a way that its residues interact with lipid molecules. 
4.3.1.4 Secondary Structure Analysis 
The secondary structure variations of each residue were determined by DSSP [34] and 
plotted against time for each structure (Figure 4.7).   The program analyses the 
secondary structure of a protein by a pattern-recognition process of hydrogen-bonding 
patterns and geometrical features extracted from X-ray coordinates.    Although 
AKHR is a flexible membrane protein, most structural features found in the initial 
structures were maintained during molecular dynamics. 
4.3.1.4.1 Secondary structure Analysis of helix bundles 
GPCRs are characterized by seven trans-membrane α-helices that form the core of the 
receptors.  The flexibility and stability of these helices are crucial for ligand binding 
and receptor activation.   During free MD simulation, the helices (blue regions in 
Figure 4.7), showed a high degree of stability due to the presence of the motion 
restricting membrane, interhelical interactions and a disulphide bond between Cys197 



























Figure 4.7: Secondary structure for each residue as a function of time for o_akhr10, 







All three structures, o_akhr10, o_akhr15 and o_akhr20, had high percentages of α-
helicity in the 7TM region.   The highest percentage was in H1 (residues 47-75), of 
o_akhr20 with only two intracellular residues, forming turns (yellow) towards the end 
of the simulation.    In contrast, two extracellular residues, His47 and Ile48 in 
o_akhr10 switched from α-helicity to turns and 3-helix from 75ns of simulation and 
in o_akhr15 a turn involving Ser61, Ala62 and Thr63 was on and off from 5ns until 
the end of the simulation. 
Most helices in AKHR were characterised by deformations due to the 
presence of proline and serine, especially in H2, H3, H5, H6 and H7.   Experimental 
work by Fu, D. et al, 1996 [36] has shown that proline-induced kinks involving the 
highly conserved motifs in H5, H6 and H7 are common features in transmembrane 
helices and cause twists in the helix.   The presence of serine and threonine in the 
helices modulated the formation of kinks [37] and resulted in turns and bends at serine 
positions in H5.    
Due to the presence of proline in H2, (residues 84-111), the helix had the most 
distortions involving mostly extracellular residues Met101 to Pro103, Gly107 and the 
highly conserved Asp94.   Figure 4.8 shows the structural fluctuations in H2 at 20ns 
intervals.   Pro103 induces flexibility in the helix causing the secondary structure to 
fluctuate between turns, bends and 3-helix turns during the simulation.   The highly 
conserved Asp94 plays an important role in interhelical interactions that stabilise the 






















Figure 4.8: Fluctuations in structural features in helix 2 (H2) depicting alternating 
helical turns and coils at Asp94, Pro103 and Gly107 positions 
 
The changes from α-helix to a turn (yellow) destroy this salt bridge and that caused 
the helix to drift away from H3. 
Although H3 was relatively stable, in o_akhr20, Ser136 and Phe137 formed 
short turns between 60ns and 70ns and the last intracellular residue switching to and 
from α -helicity during the dynamics (Figure 4.7).   In o_akhr10 and o_akhr15 the 
number of residues with α-helicity was reduced by 3-4 in the intracellular side of the 
receptor.   H4 (residues 162-176) maintained α -helicity but increased in length by 
three residues in the extracellular side which then turned into a 3-helix at 20ns in all 
structures and deformation of the helix was observed at Leu174.  Apart from the 
formation of turns in H5 (212-241) due to the presence of proline and serine, the helix 






On the other hand, H6 (residues 262-292) lost α -helicity in most of its 
intracellular and extracellular residues from about 20ns to 80ns in o_akhr10 and 
o_akhr15 during the simulation.   In o_akhr20, the α-helix was stable and turns were 
formed involving the highly conserved motif CWTPY [37] that contains a proline.  
H7 (residues 305-325) contains a proline in the highly conserved motif NPVVY, that 
caused the α-helix to shift to 3-helix from Ser317-Pro321 for the first 20ns and then a 
turn was formed for the greater part of the simulation in o_akhr10 and o_akhr20.   
However, in o_akhr15, this helix was very unstable and lost α-helicity in all residues 
between 60ns and 70ns.   There was an outward drift of H7 and a change from α-helix 
to 3-helix and a turn from Thr315-Ser317 just above the proline induced kink.  
Residues in H7 participate in ligand binding in most GPCRs [6, 9], so these changes 
could be crucial in the activation of AKHR.   This receptor also contains the eighth 
helix (H8) perpendicular to the membrane plane, which was stabilised by polar 
interactions with residues in H1 and H7 in all but o_akhr15.   The secondary 
structures of the residues in this helix alternated between α-helix and 3-helix and in 
o_akhr15, it disappeared after 60ns.  
4.3.1.4.2 Secondary Structure Analysis of loop domains 
The extracellular and intracellular loops, N- and C-termini were characterised by 
bends, coils and turns.   However, distinct structural features were seen in the N-
terminus, ECL1 and ICL3.   The N-terminus and ICL3 contained a 3-helix from 
Glu32-Tyr35 and Val258-Gly260, which were ‘on and off’ in all simulations.   These 
structural features are supported by the presence of a helical turn in the crystal 
structure of rhodopsin from Tyr29-Leu31 [39] and the modelled third intracellular 





terminus and the first extracellular loop, ECL1, first appeared from 25ns and 
reappeared from 40ns until the end of the simulation.   In o_akhr10, the β -sheet 
existed for the first 20ns and was absent in o_akhr15.   Since these domains are not 
usually included in crystal structure determinations, these features could be common 
to all Class A GPCRs and might be crucial in receptor activation and ligand binding.   
In contrast to the second extracellular loop in rhodopsin and β2AR, AKHR does not 
have a helical turn or β-sheets in its second extracellular loop.   The loop maintained 
an upward position above the helix bundle to pave way for diffusible ligands. 
4.3.2 Molecular Dynamics simulations of rhodopsin-based AKHR   
The starting structures, c_akhr10, c_akhr15 and c_akhr20, for the three 100ns MD 
simulations of the rhodopsin-based AKHR, were extracted from a trajectory generated 
from MD simulation of the model in a membrane, with fixed helices at 10, 15 and 
20ns.   During MD simulation, the overall structure of the molecule and predicted 
helix regions were maintained.  As observed in the β2AR-based structures, the 
molecule is highly flexible and fluctuations of the Ca atoms depend on the structural 
domains as shown by the rmsf values in Figure 4.9a.   All three simulations had 
similar fluctuations.   Even though movements in H2 (82-111) were relatively high, 
the helix bundles were fairly rigid, especially in simulation c_akhr20 (black) where an 
effective hydrophobic environment around the bundles was created by the membrane.   
As expected, the highest movements were found in the termini as well as the extra and 
















      









     (b) 
Figure 4.9: The rms fluctuations of c_akhr10 (red), c_akhr15 (green) and c_akhr20 
(black) as a function of time during the 100ns MD simulations.  b) A comparison of 
fluctuations in c_akhr20 (blue) and o_akhr20 (black). 
 
Highest fluctuations with rmsf of ~ 0.6- 1.4nm were found in the first residues in the 
N-terminus (1-46).   This part of the structural domain is stretched away from the rest 
of the molecule, intermolecular interactions are minimal and have no contact with 
residues in neither the molecule nor the membrane.  
 A comparison of simulations o_akhr20 and c_akhr20 points out that 







4.9b).   Except for the N-terminus, o_akhr20 has a higher rmsf values in most of its 
extracellular and intracellular regions, especially in ICL3 (243-264), ECL2 (177-211) 
and residues 23-41 in the N-terminus which have rmsf of ~ 0.5nm.  In rhodopsin-
based AKHR, the residues are closely packed, flexibility is reduced due to steric 
hindrance and presence of a dense network of H-bonds and hydrophobic interactions.  
 
4.3.2.3 Deviations of molecular structures from the initial structures.  
 Figure 4.10 shows the root mean square deviations (rmsd) during the 100ns MD 
simulations.  These values indicate the structural equilibration and the range of 
molecular deviations from the initial structures of simulations c_akhr10, c_akhr15 and 
c_akhr20 (Figure 4.10a).   In all three simulations, there were significant deviations 
from the initial structures that gave rise to initial rmsd of ~0.3 to 0.4nm.     
   (a)               (b) 
Figure 4.10: a) Variation of the rmsd values during 100ns MD simulations of the 
closed AKHR structures.   The rmsd reached steady state after 30ns but there were 
fluctuations until 70ns in c_akhr15 (green) and c_akhr20 (black). (b) Comparison of 
rmsd of o_akhr20 and c_akhr20 simulations.    The systems are very similar and both 






Although the three systems are similar, simulation c_akhr10 reached a steady state 
after 30ns and all systems attained stable conformations after 70ns and maintained 
rmsd of ~0.59nm.   The same rmsd was attained in the β2AR-based structures and the 
similarity between c_akhr20 and o_akhr20, is illustrated in Figure 4.10b.   Both 
systems had a sudden increase in rmsd to ~0.4nm within the first 2ns of simulation 
and finally gained stability 70ns.   Therefore, for a given molecule, the final rmsd is 
independent of the starting structure used.     
4.3.2.4 Compactness of the protein molecules 
From the variations of radius of gyration (Rg) values of the structures of rhodopsin-
based AKHR during 100ns MD simulations in Figure 4.11, the most compact 













Figure 4.11: a) Rg variations of rhodopsin-based AKHR during 100ns MD 
simulations of c_akhr10 (red), c_akhr15 (green) and c_akhr20 (black). The systems 
reached steady state after about 50ns. Structures from c_akhr10 have the lowest 







In simulation c_akhr15 (green), the molecule was loosely packed resulting in an 
average Rg of ~2.46nm.   However all systems reached steady state after 50ns and 
approach final Rg of ~2.40-2.45nm.    As expected, the ‘closed’ rhodopsin-based 
structures are more compact than the β2AR-based AKHR.  This is illustrated by ~5% 
change in Rg of rhodopsin-based structre in contrast to ~14% in β2AR-based AKHR. 
4.3.2.1 Conformation Changes during simulations 
The closed conformation of the rhodopsin-based AKHR was maintained during the 
100ns MD simulations in all simulations.   However, an overlay of structures from the 
three simulations gave an rmsd of 0.3 + 0.02nm from the vacuum structure, showing 
that there are conformational and structural changes that cannot be ignored. 
 
4.3.2.1.1 Conformational Changes in the Helix bundle 
The general structure and anticlockwise arrangement of the helix bundles was 
maintained but there was a slight movement of helices away from each other 
especially in H1, H3, H6 and H7.   In Figure 4.12, the arrangements and positions of 
the helices of the structures in simulation c_akhr20 at 20ns intervals are shown.   The 
movements of helix 1 illustrate the shift of residues and preservation of the closed 
conformation in the rhodopsin-based structures (H1).   H1 shifted downwards and 
slightly outwards by ~0.18nm from its initial position, in contrast to the marked 
outward divergence of ~0.6nm in the β2AR-based structure.   The small outward 
movement of the helix increases its distance between H2 and H7 and enlarges the 




















Figure 4.12: An overlay of the helices of rhodopsin-based AKHR indicating their 
positions at, 0ns (orange), 20ns (purple), 40ns (pink), 60ns (yellow), 80ns (cyan) and 
100ns (green).   
 
However, the bend at Ser61 and Thr63 was preserved and this kept the extracellular 
half of the helix drawn towards the centre of the helix bundle, upholding the open 
conformation.   The closed conformation of a GPCR is found only in the crystal 
structure of rhodopsin and is essential for the protection of the covalently bound 
ligand, 11-cis-retinal [33].   These movements could indicate the position of the helix 
when AKHR is in one of its activated state.    
 During MD simulation of β2AR there was an inward movement of H3 and H6, 
resulting in intermittently formation of an ‘ionic lock’ between intracellular residues 
[1].  Even if the same movements were observed in the β2AR-based AKHR, an ‘ionic 






(H3) and Lys263 (H6) in the initial structure of the rhodopsin-based AKHR was 
broken (Figure 4.13).  







Figure 4.13:  An overlay of the intracellular end of helix 3 (H3) and helix 6 (H6) in 
the starting structure (cyan) and c_akhr20 (purple) after 20ns of simulation.  Sticks 
give the positions of Arg146 and Lys263 side chains in H3 and H6 respectively.   The 
red dotted line represents the ionic bond between Arg146 and Lys263. 
 
This is because, upon MD simulation, the helices moved away from each other, 
increasing the distance between Arg143 and Lys263 from 0.28nm to 1.42nm (Figure 
4.13).   An outward movement of these helices is typical during activation of GPCRs 
and in rhodopsin this leads to breaking of the ‘ionic lock’ [32,33,40].   The closed 
extracellular region and the outward movement in the intracellular region of the helix 
bundles of AKHR is in line with conformations in activated GPCRs and supports the 
idea that the rhodopsin-based AKHR could represent the bound conformation of the 
receptor.  
4.3.2.1.2 Conformational Changes in loop domains 
From the rmsf values in Figure 4.9, there was minimal movement of the loop domains 
in rhodopsin-based AKHR compared to β 2AR-based AKHR.  In the extracellular 






domains over the helix bundles and the closed conformation.  Although the N-
terminus had conserved conformation from residues 10-46, its amino end had 









Figure 4.14: An overlay of the ribbon structure of the N-terminus of rhodopsin-based 
AKHR giving conformations at 20ns interval during the simulation.  The amino end, 
Met1-Asn10, is highly flexible and has undefined structure. 
 
Though the overall structure of the carboxyl end is similar to that of β2AR-based 
AKHR, the terminus is collapsed over the helix bundles, a position similar to that of 
the N-terminus in the crystal structure of rhodopsin [40].  
  Even though the second extracellular loop (ECL2) does not have β-sheets as 
found in the crystal structure of rhodospin [39], it is crumpled over the helix bundle 
and lies below the N-terminus, ECL1 and ECL3.   The loop is kept in position by the 
Cys197-Cys212 disulphide bond and formed a cap over the helix bundle closing 
possible binding sites.      In contrast, in the crystal structure of β2AR [22] and β2AR-
based AKHR, ECL2 is withdrawn away from the centre of the helix bundle, exposing 
it more to the solvent and is positioned above the ECL1 and ECL3 to leave space for 






 Whilst ICL2 was drawn out and upwards from the helix bundle, the most 
flexible part of the intracellular loop domains, ICL3 (22 residues), was opened up as 
H6 moved away from H3 and H5.  However, the loop has a preserved conformation 










Figure 4.15: An overlay of the third intracellular loop in rhodopsin-based AKHR at 
20ns intervals during the simulation. 
 
A helical turn that was observed in the modelled β 2AR ICL3 loop [1] and in 
previously discussed β 2AR-based AKHR is seen from Ser250-Ser254 in the 
rhodopsin-based AKHR.   In contrast to β2AR-based AKHR, the secondary structure 
occupies the most flexible part of the loop and hence its position shifts during 
simulation.   The recurrence of the helical turn, in ICL3 of different receptors could be 











4.3.2.2 Secondary Structure Analysis 
The DSSP programme was used to analyse the secondary structure of rhodopsin-
based AKHR molecules and the results are given in Figure 4.16.   It was observed that 
the helical regions (blue) of the receptor were maintained during the 100ns MD 
simulations.    Whilst some structural features in the highly flexible extracellular and 
intracellular loop regions were preserved, the intracellular helix (H8), which is 
normally parallel to the membrane surface, was surprisingly unstable in all three 































Figure 4.16: Secondary structure for each residue as a function of time for akhr10, 






4.3.2.2.1 Secondary Structure Analysis of helix bundle 
In all three simulations, the α-helices were relatively stable, even though the presence 
of proline, serine and threonine induced distortions in H2, H3, H4, H5, H6 and H7 
[40,41].   The percentage α-helicity increased from simulation c_akhr10 to c_akhr20 
and this could be attributed to the contribution of the lipid molecules to the stability of 
the helix bundles.  The membrane creates a hydrophobic environment for the helix 
bundles and induces helix structures in the transmembrane regions [41].   Tight 
packing of lipid molecules around the helix bundles in c_akhr20 allows for efficient 
intercalation of the aromatic side chains with the lipid chains [42] and increases the 
formation of interhelical hydrogen bonds [43,44,45].   
Whilst helix distortions were absent in H1 of β 2AR-based AKHR, in 
rhodopsin-based AKHR the helix is characterised by deformations due to the loss of 
α-helicity from Ala54 to Gly64 in c_akhr10 and Tyr54 to Thr56 in c_akhr20.   The 
turns provided a flexible hinge for the helix to be drawn towards the centre of the 
helix bundle in the closed conformation.   On the other hand, H2 displayed proline-
induced kinks in all simulations.   Unexpectedly 30% of residues in H3 lost α-helicity, 
especially in c_akhr10 where some residues formed 5-helix.  In addition to the 
proline-induced kinks in H5, at Met220 -Thr222, and H6, at Val278-Trp281, the 
helices reduced in length by three residues at both the extracellular and intracellular 
ends in c_akhr10 and c_akhr15.   Except for the loss of α-helicity by residues at the 
intracellular end of H6, both helices were fairly stable in c_akhr20.   In simulation of 
c_akhr10, more than 50% of residues in H7, formed turns and the helix almost 
disappeared during the simulation.   However, α-helicity was maintained in c_akhr15 





Surprisingly, H8, which was very stable in β 2AR-based AKHR and is commonly 
found in Class A GPCR [26], disappeared after 30ns in all simulations.   
Helix-helix interactions contribute more to the final stage of structure 
formation of membrane proteins [41] and stabilise GPCRs in their inactive states.  
The instability of most α -helices in the rhodopsin-based structure could be due to 
unfavourable contacts between the side chains of the residues and steric hindrance.   
This is because the closed conformation of the rhodopsin template resulted in a closed 
packing of residues in the helix bundle of the receptor model.   In an attempt to avoid 
these contacts, a high percentage of the residues in the helix bundle lost α-helicity.   It 
was observed that the largely hydrophobic side chains of an α -helix contact the 
hydrophobic membrane core [46] especially when the lipid molecules were closely 
packed to stabilise the helix bundle.   This was not the case in c_akhr10 and c_akhr15 
simulations where the lipid molecules were loosely packed, hence high distortions 
were observed. 
4.3.2.2.2 Secondary Structure Analysis of loop domains 
Coils, turns and bends were a common feature in the termini, extra and intracellular 
loop domains of the receptor in all simulations.   The N-terminus also had flashes of a 
310-helix from Asn3-Ala6 for the first 12ns which was ‘on and off’ from 20ns to 80ns.   
Although a second helix appeared at a similar position to that in the N-terminus of 
β2AR-based AKHR and the crystal structure of rhodopsin [39], a β-sheet was formed 
briefly from residue 39-40 during the c_akhr10 simulation.   In addition, the salt-
bridge found between Tyr24 and Thr115 in β 2AR -based AKHR was absent in the 
rhodopsin-based structures.   The N-terminus and EC1 are further apart from each 





bundle, reducing the chances of contacts with residues in the N-terminus.   Whilst β-
sheets found in ECL2 of rhodopsin [39], are absent in the same loop of AKHR, a 
transient 3-helix was formed close to the extracellular end of H5, which appeared to 
be an extracellular extension of the helix.  
 In the intracellular region, a 3-helix was formed in ICL3 throughout the 
simulation.  This structural feature involved residues Ser250-Ser254 at the centre of 
the loop and is comparable to the helical turn found in the third intracellular loop of 
β2AR during MD simulations in a membrane [1].   In the β2AR-based structures, the 
helix appeared at a more rigid position involving residues Asp257-Gly260, which are 
close to the intracellular end of H6.  As has been noted earlier, the presence of a 
conserved helical turn in ICL3 could be important in G-protein activation. 
4.4 Conclusion 
MD simulations to optimise the β2AR-based and the rhodopsin-based adipokinetic 
hormone receptor in their inactive states have been successfully performed.   MD 
simulations of GPCRs in vacuum are usually performed with fixed helices to maintain 
α-helicity but in membrane simulations, this is not necessary as the membrane 
stabilised the helices.   In its true environment, β2AR-based AKHR prefers a wider 
helix bundle whereas the rhodopsin-based structure maintained a closed 
conformation.   The open conformation would allow for the free movement of the 
large AKH peptides in and out of the binding site.   Although the rhodopsin-based 
model had an ionic bond involving the highly conserved Arg146, it was observed that 
this ionic bond is absent in both AKHR models during molecular dynamic 
simulations.   The extracellular and intracellular domains have conserved 





These structural domains consistently form β -sheets and helical turns, especially in 
β2AR-based AKHR.   These structural features could be important in ligand binding 
and receptor activation.   An important observation is that β2AR-based AKHR has 
stable, seven transmembrane helices, which are crucial for ligand binding and 
receptor activation in GPCRs.   The stability, conformational and structural changes 
of AKHR during MD simulations indicate that close packing of the membrane 
molecules around the helical bundle, as in o_akhr20, stabilised the helices and 
maintains α-helicity.   The 3D structure of AKHR from the mosquito and the study of 
its molecular dynamics gives insights into the structures of insect GPCRs and pave 
way for docking studies that could lead to the design of non-peptide mimetics that can 
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Docking calculations: Identification of binding pocket in AKHR and 
MD simulations of bound receptor.  
5.1 Summary 
The binding site and accessibility of the binding pocket in AKHR were determined by 
perfoming blind docking (BD) calculations of the adipokinetic hormone, Del-CC 
(pGlu-Lys-Asn-Phe-Ser-Pro-Asn-Trp-Gly-Asn-NH2) using Autodock4 and Autodock 
Tools [1,2,3].  It was observed that the helix bundle and the extracellular domains 
defined the binding pocket of AKHR.   The open β 2AR-based AKHR structure 
facilitated hormone binding, whilst the closed rhodopsin-based model had limited 
access of the binding pocket.   To determine the effect of ligand binding on the 
conformation of the receptor, MD simulations of AKHR bound to an active insect 
AKH were performed.   Upon MD simulation of β2AR-based AKHR-ligand complex, 
there was a sudden shift from an open to a closed conformation of the helix bundle in 
the extracellular side of the receptor within the first nanoseconds of simulation.   
Simultaneously, in the intracellular side helices H3, H5 and H6 moved away from 
each other.  The protein-ligand complex was stabilised by an intense network of H-
bonds and formation of salt bridges between residues in the helices and the 
extracellular loop domains, and the ligand.  Tyr285 in H6 was bound to the ligand 
throughout the simulation and could play an important role in ligand binding and 





5.2 Experimental Methods  
5.2.1 Docking Calculations 
5.2.1.1 Identifying the binding pocket of AKHR 
Blind docking (BD) calculations [4,5,6] of Del_CC were perfomed using Autodock4 
and Autodock Tools  [1] to identify the binding site and accessibility of the binding 
pocket of the β2AR- and rhodopsin-based 3D structures of AKHR.   BD is a method 
that involves scanning the entire extracellular surface of the receptor by the ligand to 
identify suitable binding sites in the receptor.   Autodock has been found to be useful 
in blind docking where the location of the binding site is not known [4,5,7,8,9,10].   
The highly active adipokinetic hormone, Del-CC (pGlu-Lys-Asn-Phe-Ser-Pro-Asn-
Trp-Gly-Asn-NH2), [2,3] which regulates mobilisation of carbohydrates in the blister 
beetles, was used as the ligand since its structure was readily available in our 
laboratory.    
Docking parameters for macromolecules and the ligand (Appendices D and E) 
were set based on those used by Hetenyi et al [4].   The β2AR-based receptor model 
was used in the determination of the binding site and the two models were used in 
determining the accessibility of the pocket from the extracellular side.   Based on the 
positions of the binding pockets in rhodopsin and β2AR [11], a variety of grid maps 
were generated in the extracellular region of β 2AR-based AKHR, using the 
AutoGrid4 program [1,4,5].    The most suitable grid map with grid points of 64 x 64 
x 50 in xyz, and a spacing of 0.05nm, was used for the for blind docking calculations.   
The grid box was centred at the Lsy306 HZ1 atom, to include all residues with side 
chains oriented towards the centre of the helix bundle.   The ligand was flexible with 





generate conformations of the ligand within the binding pocket [1,6,7,8].   For a 
population size of 150, the maximum number of generations and energy evaluations 
were set at 100 x 106 and all other parameters were set to default AutoDock4 values.  
The molecule was subjected to 50 trials of BD for 100 runs, to search for the binding 
site in AKHR.   Cluster analysis was executed at a cut-off of 2Ǻ.   For the first four 
trials, the conformation of lowest energy was obtained from the most populated 
cluster and the results were used to carry out more focused BD calculations.   Results 
from these calculations confirmed the position of the binding pocket of AKHR.   
From the protein-ligand complex with lowest estimated free energy of binding (∆Gb) 
[6] the binding pocket of AKHR was identified.   To determine the accessibility of the 
binding site, in the rhodopsin-based model, the procedure was repeated using grid 
points 64 x 50 x 66 in xyz.  
5.2.1.2 Identifying the binding mode of Del_CC 
To determine the binding mode of Del_CC and refine the docking, further 
calculations were performed for 100 runs using a rigid receptor molecule and a 
flexible ligand with 32 released torsion angles.   Both ligand and receptor parameter 
files were prepared using Autodock Tools (Appendix).   Grid points (64 x 64 x 50 in 
xyz) which focused on the preferred binding pocket, were applied to generate grid 
maps with a spacing of 0.05nm using the program AutoGrid4.   A total of 500 x 106 
generations and energy evaluations, and LGA were applied for a population of 300.   
From the results, the conformation of lowest ∆G b was used to further optimise the 





5.2.2 Molecular dynamics (MD) Simulations of bound AKHR in a Membrane 
To further optimise the docking, MD simulations were carried out with both protein 
and ligand molecules flexible.   The protein-ligand complex of lowest ∆G b from 
section 5.2.1.2, was inserted into a previously prepared membrane (Chapter 4) to 
represent its true environment.   This gave the receptor/membrane complex shown in 









Figure 5.1: A complex of docked AKH/Del_CC (blue) and the receptor, AKHR 
(orange) inserted into a POPC membrane (green).   Water molecules are not shown. 
 
Based on the MD simulation results in Chapter four, the system was energy 
minimised for 3000 steps of L-bfgs and equilibrated by subjecting it to position 
restrained MD simulations for 20ns to effectively soak the protein by the lipid and 
water molecules.   The starting structure extracted after 20ns was subjected to 100ns 
MD simulations by applying the protocol and parameters described in Chapter four.     
Structures extracted from the MD trajectory at 10ns intervals were rescored to obtain 
the final values of the estimated free energy of binding.   The modified scoring 
function of Autodock 3.0 described by Hetenyi, C et al [12] for large and flexible 






5.3 Results and Discussion 
5.3.1 Identifying the binding pocket of AKHR 
From the 50 trials of blind docking, the ligand, Del_CC, occupied a position defined 
by the helix bundle, the N-terminal and the extracellular loop domains.   In this 
putative binding site the ligand was in close contact with residues in helices 2, 3, 5, 6, 
and 7, the N-terminus, ECL2 and ECL3.   Figure 5.2a gives the surface of the 
extracellular side of the receptor indicating the position of the agonist in the binding 
pocket and the interactions between Del_CC and helix residues are given in Figure 
5.2b.  
 
     
 
  (a)              (b) 
 
Figure 5.2:  a) Surface of AKHR (yellow) indicating the ligand, Del_CC (coloured 
by atom) occupying the binding pocket in the receptor.   b)  Helices 2, 3, 5, 6, and 7 
defining the binding pocket of adipokinetic hormone receptor (orange).   The 
ligand, (blue) forms hydrogen bonds with Gln209 (second extracellular loop, not 
shown), Lys307 (third extracellular loop), Tyr285 (H6) and Tyr221 (H5).    
 
The position of the putative binding pocket and involvement of the N-terminus, 
extracellular loop domain and the extracellular end of the helices, in AKHR is in good 
agreement with experimental data from mutational mapping of binding sites for 







the tachykinin system, the exchange of the extracellular loop segments between 
neurokinin-1 and neurokinin-3 receptors have shown that the extracellular domain and 
the helix bundle are both involved in binding [15,16].  Chimera studies of insect 
peptide GPCR, Pheromone-biosynthesis-activating-neuropeptide receptor (PBAN-R), 
also demonstrated the importance of the extracellular domain and the disulphide 
bridge in ligand binding [17,18].   This position was also similar to the location of the 
binding pocket in the human gonadotropin releasing hormone receptor [19] but differs 
from that of rhodopsin and β2AR, which are buried inside the helices [14,20]. 
Having obtained the position of the preferred binding site of AKHR, more 
focused docking was carried out to determine the binding mode of Del_CC.   It was 
found out that in the conformers of lowest estimated free energy of binding, the ligand 
formed H-bonds and salt bridges with Tyr221, Tyr285, Gly209 and Lys307 as shown 
in Figure5.2b.    ΔGb for ligand/receptor binding was  -38.5 kJ/mol with an estimated 
inhibition constant of 168 nM.   This indicates that the receptor has high affinity for 
Del_CC.   The protein-ligand complex is stabilised by an intense network of H-bonds 
and ionic interactions between the receptor and ligand residues.  
5.3.1.1 Accessibility of the binding pocket in β2AR- and rhodopsin-based AKHR 
AKHs occur as octa-, nona-, or decapeptides that are released from the brain into the 
circulatory system of the insect body [21,22].   At the fat body, the ligands enter the 
binding pocket of their GPCRs from the extracellular side [22,23,24].   Accessibility 
of the binding site by these diffusible ligands is therefore crucial for ligand binding.   
When the hormone, Del_CC, diffused into the binding pockets of both AKHR 





(Figure 5.3a) to occupy the putative binding site.   In contrast, in the closed, 
rhodopsin-based conformation of AKHR, while it was possible to force the ligand 
into the identified binding pocket, the space between the helices, loops and the N-
terminus was too small to allow the ligand free access to the pocket from the 
extracellular side.    Instead it was found to bind to the periphery of the binding pocket 





 (a)        (b) 
Figure 5.3: Binding pocket accessibility of (a) the β2AR-based and (b) the rhodopsin-
based AKHR. The ligand is right inside the binding pocket in the β2AR based AKHR 
but only occupies a peripheral position in the rhodopsin based AKHR.  
 
As observed earlier, the use of rhodopsin and β 2AR as templates for the helix 
bundles results in models of AKHR with different conformations.   β 2AR-based 
AKHR has an open conformation, that gives room for free movement of the ligands in 
and out of the binding pocket due to open cavities on the extracellular surface (Figure 
5.4a).   On the other hand, the rhodopsin-based structure has a closed conformation 
that does not leave accessible cavities on the extracellular surface of the receptor 










  (a)        (b) 
Figure 5.4: Surface structure of a) the β2AR-based 3D structure of AKHR. The black 
ring shows the deep cavity between H1, H7 and N-terminus in the extracellular region 
of the receptor. b) The rhodopsin-based 3D structure of AKHR.   There was no opening 
between H1, H7 and N-terminus as indicated by the black ring. 
 
The loop domains and the helices of closed AKHR are drawn close to each 
other, therefore, the accessibility of the binding pocket is reduced and hormone access 
is inhibited.   It is important to note that, when the grid map was focused on the 
putative binding pocket during docking with rhodopsin-based AKHR, the ligand was 
forced into the binding site and the lowest ∆Gb was higher than +100 kJ/mol.    It is 
postulated then, that the β2AR-based structure could represent the conformation of the 
bound/inactive AKHR, while the rhodopsin-based structure could give information on 
the active, bound, state of the receptor. 
5.3.2 Molecular dynamics Simulations of bound AKHR in a Membrane 
Since docking calculations were executed with a rigid protein molecule and 
Autodock4 performed structural optimisation of the ligand, MD simulations were 
performed to further refine and optimise the β 2AR-based AKHR-ligand complex of 
lowest ∆Gb [6] in a typical bilayer membrane environment.   The MD simulations 






after binding to an agonist.   In addition, the stability and mode of binding of the 
adipokinetic hormone, Del_CC, in the putative binding site were investigated. 
5.3.2.1 Conformational Changes in bound AKHR 
 There were drastic conformational changes in the whole receptor molecule within the 
first 1.5ns of MD simulations of bound AKHR.    These were maintained throughout 
the simulation as the molecule converted from an open, inactive, to a closed, active, 
state.  This drastic receptor response to activation by the AKH is in contrast to the 
slow transition of β2AR to its active conformation during dynamics of the adrenaline 
(epinephrine) bound receptor [25].    However, the fast attainment of the active 
conformation by AKHR is consistent with the high activation rates observed when 
noradrenaline induced changes in fluorescently labelled β 2AR in a detergent, with 
half-lives of 2.8 and 70s for the fast and slow phases and within ~40ms [26,27,28,29].  
Changes in conformation of the protein molecule in the presence of the ligand 
were induced by the mobility of the atoms.   A comparison of the mobility of the 
atoms in unbound (o_akhr20) and bound AKHR is given by the rmsf of the Ca atoms 
for each residue during a 100ns simulation (Figure 5.5).    The results reflected similar 
mobility in most parts of the molecules in both simulations.   As expected large 
fluctuations, rmsf of ~ 0.4-0.5nm, were seen in the loop domains and the termini.   In 
contrast to rmsf of ~0.1nm for the helices of o_akhr20 (black), the helix bundles of 
bound AKHR were highly mobile as shown by high rmsf of ~0.2nm for H1 (47-75), 



















Figure 5.5:  The rms fluctuations of o_akhr20 (black) and bound AKHR (blue) as a 
function of time, during 100ns MD simulations.  
 
This could be attributed to the changes from α-helicity to turns and bends especially 
in H1 and H7 (308-325) as the helices interacted with the ligand.   Mobility of helices 
was also observed in the photoactivated form of rhodopsin as illustrated by the 
movements of the middle part of H3 [30].   In o_akhr20, the helices had low 
flexibility and dynamics as indicated by low B-factor values since the tightly packed 
membrane molecules restricted motion.    However flexibility and mobility of helices 
in the presence of an agonist are essential for receptor activation  [31,32] and accounts 
for the drastic change in conformation of the receptor during ligand binding.    
 The high molecular movements and the structural changes account for the 
high deviations of the bound AKHR molecule from its starting structure as shown by 
the rmsd in Figure 5.5 for both unbound (black) and bound (blue) AKHR.   Both 
simulations deviated from their starting structures but the bound receptor deviated the 






   (a)      (b) 
Figure 5.5: Variation of the rmsd values during 100ns MD simulations of unbound 
(black) and bound (blue) AKHR. (a) Rmsd for both unbound AKHR structures and 
the bound structure initially increased to 0.30 – 0.40nm.  b) Helices in bound AKHR 
attained equilibration after 40ns and there was an increase until the end of the 
simulation.  
 
Within the first 1.5ns of simulation, there was a steep rise in rmsd to ~0.45nm 
as helices were drawn inwards in the extracellular region and outwards in the 
intracellular region of bound AKHR.   From about 10-40ns, the system reached steady 
state with an rmsd of ~0.53nm.   High fluctuations from 2-18ns were due mainly to 
the collapse of the highly flexible extracellular and intracellular domains.   A closer 
look at the rmsd of the helices indicated that conformational changes in helices due to 
ligand binding contributed more to the deviations than did the loop regions (Figure 
5.5b).   The helices reached steady state from 2 – 40ns with an rmsd of ~0.35nm.   
However, there was a steady rise in rmsd from 40 – 100ns due mainly to changes 
from α -helical to 3-helical, turns and bends of some residues in the helix bundle.   
This indicates that the molecule had passed its steady state period and given more 






Irrespective of the high deviations and fluctuations in bound AKHR 
molecules, the radius of gyration (Rg) values [33,34] shown in Figure 5.6, indicated 
that the molecule was more compact than unbound AKHR in both systems.   The 
initial Rg was ~2.43nm and an average Rg of ~2.47nm was attained during the 











Figure 5.6: Radius of gyration as a function of time for o_akhr20 (black) and bound 
AKHR (blue) during a 100ns MD simulation.  
 
Fluctuations in Rg of bound AKHR could be due to the changes in secondary 
structure within the helix bundle as shown from the analysis results by DSSP.   On the 
other, hand, the initial Rg for the unbound receptor was higher by ~6% and its 
average by ~1%.   From these results, it can be concluded that ligand binding 









5.3.2.1.1 Conformational Changes in helix bundle 
 Although the overall structure of the AKHR molecule was maintained, ligand 
binding induced a variety of conformational changes in the helices of the β2AR-based 
AKHR model.   There was an inward movement of the helices in the extracellular 
region and an outward shift in the intracellular region within the first 1.5ns of 
simulation.   The change in conformation is clearly shown by an overlay of unbound 
and bound AKHR molecules after simulation (rmsd) shown in Figure 5.7 (movie on 






Figure 5.7a: An overlay of unbound (brown), and bound (green) AKHR helices.  In 
both structures, the helix bundles are very stable and most residues maintained α-
helicity.   An inward movement of the extracellular regions of the helices results in a 
closed conformation, similar to that of rhodopsin-based AKHR.  Consequently, in the 
intracellular region the helices moved away from each other and the loops, ICL1, 







In the extracellular side three helices H1, H5 and H7 had a significant tilt towards the 
centre of the helix bundle.   To illustrate shifts of H1 in unbound and bound AKHR 
respectively, Figure 5.7b shows the positions of this helix relative to its position in the 
starting structure.   The orientation of the extracellular terminal residue, His47, in the 
helix is also shown.    
 
 








Figure 5.7b: Positions of helix 1 in unbound/free AKHR (pink), and bound AKHR 
(light blue) relative to the initial structure of AKHR (orange) after MD simulation for 
40ns.  In free AKHR H1 is deflected outward by ~0.6 nm.  In contrast, there is an 
inward deflection by ~0.5nm and a downward shift of H1 in bound AKHR due to 
ligand binding.    Sticks show the orientation of His47 at the extracellular end of the 
helix.   
 
The Ca atom in His47 at the extracellular end of H1 was shifted outwards by 0.6 + 
0.02nm in free/unbound AKHR.   In contrast, the helix was drawn towards the centre 
of the helix bundle by ~0.4nm from its initial position in bound AKHR, to give a total 
distance of 1.0 + 0.2nm between His47 in unbound and bound AKHR.   This distance 
is equal to the distance between the ends of H1 in the β2AR-based and rhodopsin-






Upon activation by an agonist, conformation changes took place to 
accommodate the bound ligand.   During activation of GPCRs, such conformational 
changes are important for the transmission of signal from the extracellular region to 
the intracellular region of the receptor, activation of the heterotrimeric G-protein and 
production of a cascade of signal [31,32].   Similar changes have been observed in 
β2AR, when the presence of an agonist, epinephrine, caused some of the helices to tilt 
and become closer to each other [35], resulting in a closed conformation in the 
extracellular region.   These changes are crucial in that they reflect the shift from 
inactive to active state of the receptor.   
In the intracellular side of AKHR H1, H3, H5 and H6 are drawn away from 
the centre of the bundle, giving it an open conformation in that region.   Experimental 
data support the shift of H6 away from H3 in the intracellular region of activated 
GPCRs [25,31].   In rhodopsin the movement of the cytoplasmic end of H6 was 
demonstrated by, for example, restraints due to engineered metal ion binding [36].    
In β 2AR the most important movements were found to involve the outward 
divergence of H6 in the intracellular region or its clockwise rotation leading to the 
disruption of the ‘ionic lock’ [24].   Similarly, in bound AKHR, H6 was heaved away 
from both H3 and H5.   This led to the destruction of the ionic interactions between 
H5 and H6, which could lead to increased basal activity, and activation of the G-
protein. 
Rhodopsin has a covalently bound 11-cis-retinal molecule within its binding 
crevice [37,38].   This ligand is coupled to Lys296 in H7 through formation of a 
Schiff base.  The receptor therefore maintains a closed conformation in the 
extracellular region to protect the ligand from hydrolysis [11].   Likewise, the 





bundles, and the loops collapsed over the helix bundles to gain a closed conformation 
that protected the ligand.   The closed conformation of AKHR and the outward 
movement of H6, in the intracellular region indicate that AKHR/Del_CC complex 
gives an activated state of the receptor.   This conformation can be used to provide 
more information on the binding pocket, binding mechanism in insect GPCRs and 
improve the calculated binding energies for agonists [39].   In addition to the results in 
Chapter four, these observations supported the idea that the open β2AR-based AKHR 
model represented the inactive state of the receptor that shifted to a closed 
conformation upon receptor activation. 
5.3.2.2 Secondary Structure Analysis of bound AKHR 
The changes in secondary structure of each residue in bound AKHR molecule, as 
determined by the DSSP programme [40], are presented in Figure 5.8.   
5.3.2.2.1 Secondary structure Analysis of helix bundle 
As shown earlier, the blue regions indicated the α-helices, which form the core of the 
receptor and play an important role in ligand binding.   Even though ligand binding 
stabilised most of the helices, it was seen that the percentage of α-helicity fluctuated 
during simulation and drastic structural changes were induced in most helices.   
Changes were clearly seen in H1 where α-helicity in the extracellular side was stable 
until 40ns, and then His47-Leu49 shifted to a turn.   On the other hand, the 
intracellular residues shifted from α -helicity to turns, B-bridges and 3-helicity 
throughout the simulation.   The percentage of α -helicity in most residues was 






















Figure 5.8: Change in secondary structure of residues in bound AKHR during 100ns 
MD simulation of o_akhr20 (top) and bound AKHR (bottom). 
 
The change in structural features in this helix was due to the inward movement in the 
extracellular side and the outward movements in the intracellular region that accounts 
for the change in conformation and the high deviations from the starting structure 
discussed earlier. 
As shown by the o_akhr20 results, in unbound AKHR, H2 (residues 84-111) 






Pro103, Gly107 and the highly conserved Asp94.   In bound AKHR, the interactions 
between H2 residues and the ligand stabilised the helix.   However, in addition to the 
turn at Pro103 position, two to three residues in the extracellular side lost α-helicity.   
Also in H3 the turn that was formed in o_akhr20, was absent in the bound structure.   
Although turns were formed in H4 during simulations, there was a higher percentage 
of α -helicity compared to o_akhr20 especially in the extracellular side.          
Proline induced kinks, enhanced by deformations due the presence of serine 
and threonine, were a common feature in most of the helices especially in H5, H6 and 
H7 [41,42,43] and resulted in turns and bends at serine positions in H5.   These kinks 
and distortions acted as hinges for the free outward movements of the helices in the 
intracellular side, during ligand binding.   As a result, 2-3 intracellular residues in H5 
and H6 lost α -helicity.   On the other hand, there was an inward drift of H7 and a 
change from α -helicity to 3-helicity and a turn from Thr315-Ser317 just above the 
proline induced kink.  The high extent of distortions and kinks in this helix induced 
flexibility, which could be important in ligand binding and receptor activation. 
The eighth helix, a common attribute in Class A GPCRs [13,38,44], was 
stabilised by an intrinsic network of H-bonds with H1 residues.   However, turns 
where intermittently formed between 10 and 20 ns and after 50ns of simulation.   The 
main structural features in most residues alternated between α-helicity and 3-helicity.  
Since the eighth helix is believed to play an important role in G-protein activation 
[32], these changes could be important for that purpose in AKHR.  
5.3.2.2.2 Secondary structure Analysis of loop domains 
Due to high flexibility, the extra and intracellular loops, and the termini were 





receptor.   However, the 3-helix formed in the N-terminus (Glu32-Tyr35) and the 
third intracellular loop (Val258-Gly260) in o_akhr20 was preserved throughout the 
simulation of the bound receptor.    This confirmed the presence of these structural 
features in AKHR, which are also found in rhodopsin [38] and the modelled third 
intracellular loop of β2AR [44].    
On the other hand the β -sheet (red) that only appeared after 40ns in the N-
terminus (Tyr24-Tyr25) and ECL1 (Trp114-Gly117) of o_akhr20 was ‘on and off’ in 
the bound structure throughout the simulation due to participation of Tyr110 in ligand 
binding.  There was closing and opening of side chains of Thr115 in ECL1 and 
consequently, the salt bridge between Tyr24 and Thr115 was intermittent resulting in 
the ‘on and off’ β-sheets.   As in rhodopsin [45], these β-sheets formed a shield that 
aided in stabilising the ligand inside the binding pocket.    The protective effect was 
also enhanced by the inward collapse of the second extracellular loop.   This loop was 
kept in position by the Cys121-Cys197 disulphide bond.   As highlighted in Chapter 
four, the recurring helical turn and β-sheets in the N-terminus and the extracellular 
loop domains indicate that they could be present in most Class A GPCRs and are 
important in ligand binding and receptor activation.   
 
5.3.2.3 Mode of binding and stability of Del_CC 
Docking calculations involving a flexible Del_CC molecule and a rigid AKHR 
molecule generated the receptor/ligand complex.   The complex was inserted into a 
POPC bilayer membrane to more closely represent its true environment.   This was 
then subjected to 100ns MD simulations with both ligand and receptor molecules 





binding pocket of AKHR.   There was a slight change in conformation of the ligand, 
which involved an upward shift of the middle part consisting of Asn3-Asn7.   This 
part of the molecule was exposed to the extracellular loop domains and the N-







Figure 5.9:  Position and conformation of AKH (Del_CC) inside the binding pocket 
of AKHR. 
 
The N- and C-termini of the ligand were drawn closer by approximately 0.4 nm and 
downwards to interact with residues in the helices.    This conformation was stabilised 
by a dense network of intramolecular ionic bonds involving Asn3, Phe4, Pro6 and 
Asn7 (Figure 5.10).   Due to the closed conformation of the helix bundle and an 
inward collapse of the extracellular domain of AKHR, the binding pocket reduced in 
size to protect the ligand.   In addition, the adipokinetic hormone, Del_CC, was 
stabilised by H-bonds, salt bridges and hydrophobic interactions between ligand 
residues and Tyr110 (H2), Ile106 (H2), Phe126 (H3), Tyr221 (H5), Tyr285 (H6), 




















Figure 5.10: Interactions between the ligand, Del_CC (blue) and some of the 
residues in the binding pocket of AKHR after a) 20 ns and b) 40 ns of simulation.  On 
and off hydrogen bonds and salt bridges are formed between Tyr110 in H2 with 
ligand residues Leu2 and Asn3, Gln209 in ECL2 with Trp8 and Tyr221 in H5 with 
Asn10. Tyr285 formed salt bridges with either Trp8 or Gly9 or both.   
 
The participation of both the helix bundle and the extracellular domains is in 
agreement with results from mutational mapping of binding sites for peptide GPCRs 
by Fong T. H. et al, 1992 [46], and chimera studies of insect peptide GPCRs by 
Rafaeli, A, 2009 [19].  
The ligand forms polar contacts with three tyrosine residues in H2, H5 and 
H6, and glutamine in the second extracellular loop.   In Figure 5.10, it is shown that 
hydrogen bonding between Tyr110 (H2) and Gln209 (ECL2) is ‘on and off’ 
throughout the simulation.   After 20ns (Figure 5.10a), both Tyr110 and Gln209 were 






Leu2, Asn3 and Trp8 in the agonist.  This gives the residues an open orientation, 
which switches back to a closed position, as shown in Figure 5.10b. 
 Tyr285 and Tyr221 in H6 and H5 respectively played important roles in ligand 
binding by continually forming salt bridges with ligand residues.    Tyr285 formed 
ionic bonds with either or both Trp8 and Gly9 throughout the simulation as shown in 
Figure 5.10.   The clockwise and anticlockwise movements of H6 and the upward 
orientation of the side chain of Tyr285 at the centre of the helix bundle, makes it easy 
for the residue to change position of the OH atom and interact with more than one 
residue of the ligand.    The flexibility of H5 due to proline-induced kinks gives 
Tyr221 different orientations so that it has access to the C-terminus of the ligand.    
The participation of H6 and H5 side chains in agonist binding was established by 
mutation analysis of β 2AR with agonists like epinephrine, isoproterenol and related 
catecholamine compounds [26,35].    Hence, with more docking calculations the 
participation of these helices in activation of AKHR could be confirmed.  
 
5.3.2.3 Binding affinities 
Since Del_CC is a long and flexible ligand, docking calculations were rescored using 
Autodock3 [12].  Structures were extracted from the 100ns MD trajectory at 10ns 











Table 5.1: Estimated free energy of binding, inhibition constant and final 










































 (2_10ns denotes the second conformer extracted after 10ns. Other conformers are 
similarly labelled). 
 
 From the results it is shown that binding affinity for Del_CC fluctuates and most of 
the studied conformations had high affinities.    The average estimated free energy of 
binding was -33.92kJ/mol, which indicates a generally stable ligand/receptor 
complex.   
 
5.4 Conclusion 
  The binding pocket in the adipokinetic hormone receptor was succefully identified 
by performing docking calculations of an insect hormone, Del_CC and MD 
simulations of the receptor-ligand complex.   As in most peptide GPCRs, the helix 
bundles, the extracellular loop domains and the N-terminus defined its active site.   
Although both open β2AR-based and closed rhodopsin-based AKHR could 





In adition, the open conformation facilitated ligand binding by providing easy access 
to the binding pocket.    
During MD simulation, there was fast activation of AKHR that resulted in a 
change from an open to a closed conformation of the molecule in the extracellular 
region.    Simultaneously, the intracellular side of the receptor opened up, activating 
the receptor.   The agonist Del_CC, was stabilised by polar contacts with residues in 
Helices 2, 5, 6 and the second extracellular loop.   Throughout the simulation, Tyr285 
constantly interacted with the agonist and its importance in ligand binding and 
receptor activation could be verified by performing more docking calculations of 
AKH from Anopheles gambiae.  The stability of the AKHR molecule and the 
identification of its binding pocket should go a long way in the design of non-peptide 
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AKH from Anopheles gambiae : NMR Experiments, Conformational 
Search and Docking experiments.  
6.1: Summary 
The primary sequence of the most important adipokinetic hormone from the malaria 
mosquito, Anoga_akh (pGlu-Leu-Thr-Phe-Thr-Pro-Ala-Trp-NH2) was recently 
published [1].   Since no crystal structure of this neuropeptide is available, in this 
Chapter focus was on using NMR results to build the 3D structure of Anoga_akh and 
perform docking calculations of the ligand with AKHR.   Although the binding site of 
AKHR was identified in Chapter Five, it was important to perform docking 
calculations with AKH from the mosquito so that any artifects arising from 
determining the binding pocket and activation of the receptor using AKH from the 
blister beetle, Del_CC, were eliminated. 
Conformational search was done using interproton distances from Nuclear 
Magnetic Resonance (NMR) results during distance restrained molecular dynamics 
simulations of Anoga_akh.   The results have shown that Anoga_akh prefers an 
almost cyclic conformation.   This conformation is stabilised by a H-bond between the 
C-terminus and Leu2.   Docking calculations have shown that the binding pocket of 
AKHR is described by both the helix bundle and the extracellular domains.  Binding 
affinity for the ligand was higher than for Del_CC.   MD simulations of 
Anoga_akh/AKHR complex in a membrane have indicated that the ligand induced 
conformational changes in the receptor molecule.   The extracellular half of the 





polar and hydrophobic interactions stabilised the ligand and Ile106 proved to be 
crucial for binding of Anoga_akh. 
 
6.2: Nuclear Magnetic Resonance (NMR) 
Nuclear Magnetic Resonance (NMR) spectroscopy is one of the most powerful and 
widely used techniques in the study of structures of macromolecular biological 
molecules, including peptides and proteins in membrane bilayers [2,3,4,5].   
Information obtained from both one and two-dimensional spectra have been used to 
determine their secondary structures and orientations in solution and membrane [6].   
From the two dimensional Total Correlation Spectroscopy (TOCSY) [7] and the 
primary sequence of a peptide, proton chemical shifts are assigned.   It has been 
shown that there is correlation between the chemical shifts of Hα protons and the 
secondary structure of a peptide.   Thus from the assignments the secondary structure 
of the peptide can be predicted.    
Sequential assignments of the amino acid can be obtained using the nuclear 
Overhauser effect (nOe) [8].   NOe is a through space, dipolar interaction, which is 
distance dependent.   These interactions can be obtained using either the NOESY [9] 
or ROESY [10] pulse sequence.   By superimposing the NOESY spectrum onto the 
assigned TOCSY spectrum, the sequential pattern of dNN (i, i+1) and dαN (i,i+1) 
crosspeaks [8] can be established.   The assignment of the crosspeaks can be 
facilitated by floating the chirality in preliminary distance geometry calculations [11].    
Additional structural information, distance measurements between pairs of different 
nuclei and between pairs of like nuclei have been obtained on peptides in bilayers 





crosspeak intensities are estimated by the isolated spin pair approximation 
(ISPA)[12]: 
     rij = rref (aref/aij)1/6,  
Where rij is the interproton distances to be estimated and aij is the corresponding 2D 
nOe crosspeak intensity.   NMR interproton distances restraints have been 
successfully applied during molecular dynamics simulations for conformational 
search of peptides in water and in a membrane mimicking solvent like 
dodecylphosphocholine (DPC) and dimethyl sulphoxide (DMSO) [13,14,15].   
Therefore, in this work, the chemical shifts and the interproton distances were used to 
determine the flexibility and model free order parameters of AKH from the malaria 
mosquito (Anoga_akh).   The interproton distances were used as restraints during the 
molecular dynamics simulation of the peptide in water.  
 
6.3: Experimental 
6.3.1: NMR  
Sample Preparation 
Using the recently published primary sequence of the active adipokinetic hormone 
from Anopheles gambiae (Anoga_akh, (pGlu-Leu-Thr-Phe-Thr-Pro-Ala-Trp-NH2)) 
[1], the hormone was synthesised at GL Biochem (Shanghai) Ltd, China.   The 98% 
pure white powder was used in NMR experiments with no further purification.   The 
solvents used were water/D2O and a membrane mimicking solution of deuterated 
dodecylphosphocholine (DPC-d38).  
 For the aqueous phase, 1.6mg of anoga_akh was dissolved in 0.5ml of 10:1 





The same mass of  anoga_akh was dissolved in approximately 150mM DPC-d38 
micelle also buffered at pH 4 by 50mM sodium phosphate buffer.   In both cases 
trimethylsilylpropionate (TSP) was used as the chemical shift reference.  
1H NMR Experiments 
1H NMR experiments of anoga_akh were performed on a Bruker Avance 400Hz 
(Department of Chemistry, University of Cape Town) and a DRX-500MHz 
(Analytical Chemistry, University of Debrecen).   The two dimensional NMR spectra 
of the peptide in water and DPC were collected in the phase sensitive mode from 
TOCSY (mixing time, 50ms) [7,16], NOESY (mixing time, 100ms) [9] and ROESY 
(mixing time, 150ms) [10] using the WATERGATE pulse to suppress the water 
resonance [17,18].   Spectral assignments were based on the method of Wüthrich [9] 
and ISPA [12] was used to calculate the interproton distances. 
  
6.3.2: Restrained MD simulations  
The starting structure for conformational search of Anoga_akh was built using 
InsightII 2005 and energy minimised by using 3000 steps of steepest descent 
algorithm.   The molecule was subjected to 10ns molecular dynamic simulations in 
vacuum and water using GROMACS version 4.0.4 [19].   All simulations were 
performed with a time step of 2 fs, using the OPLS-AA/L all – atom [20] force field 
and constant temperature, volume and number of particles (NVT).   A cut-off 1.0nm 
was used for van der Waals interactions and electrostatic interactions for real space 
calculations. 
In vacuum 
Anoga_akh was inserted into a simulation box and energy minimised using 500steps 





according to calculated NMR interproton distances (Appendix G).   The listed 
distances were used as the lower limits and two upper limits were obtained by 
increasing the values by ~ 10%.   The molecule was subjected to 10ns distance 
restrained MD simulations at 600K and 100 structures collected.   To allow the 
molecule to overcome an energy barriers and since only one starting structure was 
used, conformational search was performed at high temperature [15].   Simulated 
annealing for 0.1ns was performed to gradually decrease the temperature of each 
collected structure to 300K.   The conformations were energy minimised, cluster 
analysis was performed with a cut-off distance of <0.2 nm.   The conformation of 
lowest energy was identified from the largest cluster.    
 
In water 
The minimum energy conformation from the simulations in vacuum was used as the 
starting structure of Anoga_akh for 10ns MD simulations in water.   The water atoms 
were based on the SPC water model [21].   To allow the water to soak the peptide, 
position-restrained MD simulations for 0.1 ns were performed.   All simulations were 
performed with periodic boundary conditions [22].   The peptide and solvent were 
coupled separately using the Berendsen coupling method to a temperature of 300K 
using a coupling constant, tau (τ)_t, of 1 x 10-4 ns. 
  Distance restrained MD simulation, based on the NMR results was performed 
for 10ns and 100 structures were collected for analysis.   Cluster analysis of the 
structures was performed based on a cut-off value of <0.2 nm for superimposing 
backbone atoms.   The minimum energy conformation from the largest cluster gave 





6.3.3: Docking Calculations 
Based on blind docking results obtained in Chapter Five, docking calculations of 
Anoga_akh were performed to determine the estimated free energy of binding and the 
binding mode of the ligand to AKHR using the β 2AR-based receptor model.   The 
AutoGrid4 program [23] was used to prepare a grid map with grid points of 64 x 64 x 
50 in xyz, and a spacing of 0.05nm, for use during docking calculations.   The grid 
box was placed in such a way that it centred at the midpoint of the putative binding 
pocket.   Docking calculations were performed with a rigid receptor but flexible 
ligand (32 active torsions angles).   Both ligand and receptor parameter files were 
prepared using Autodock Tools (Appendix).   For 30 docking trials, the Lamarckian 
genetic algorithm (LGA) was employed to generate conformations of the ligand 
within the binding pocket [23,24,25,26].   A total of 5 x 108 generations and energy 
evaluations were applied for a population of 300.   Cluster analysis was executed at a 
cut-off of 2Ǻ.    
From the results, the conformation of lowest estimated free energy of binding, 
∆Gb , was used to further refine the docking calculations using MD simulations with 
both protein and ligand molecules flexible.   The protein-ligand complex of lowest 
∆Gb was inserted into a previously prepared membrane (Chapter Four) to represent its 
true environment.   The system was energy minimised using 3000 steps of L-bfgs and 
equilibrated by subjecting it to position restrained MD simulations for 20ns to allow 
the lipid and water molecules to effectively soak the protein.   The structure extracted 
after 20ns was subjected to 100ns MD simulations whilst applying the protocol and 
parameters described in Chapter Four.   Structures extracted from the MD trajectory at 





binding using the modified scoring function of Autodock 3.0 described by Hetenyi, 
2006 [27] for large and flexible peptidic molecules.   
 
6.4: Results and discussion 
6.4.1 NMR  
Spectral assignment and interproton distances 
The 1H chemical shifts asignments for Anoga_akh in water and DPC were 
successfully performed and the results are given in Tables 6.1 and 6.2.   The 
assignments were done by referring to chemical shift tables, the primary sequence of 
anoga_akh, and by identifying the individual amino acid spin system from TOCSY 
spectra.  
  





Residue NH Hα β β’ γ γ’ δ δ’ Other 
pGlu1 7.752 4.183 2.228 1.868 2.355    
Leu2 8.275 4,236 1.445 1.355  0.750 0.702  
Thr3 7.946 4.233 3.949 0.958     
Phe4 8.154 4.494 2.853 
 
    7.08– 
7.16 
Thr5 7.961 4.314 3.797 0.968     
Pro6 -- 4.0100 1.219 1.856 1.656 3.407  
Ala7 8.200 4.004 1.145       
Trp8 – 
NH2 







Table 6.2: 1H chemical shift (ppm) assignments for Anoga_akh in DPC solution  
 
The results indicate that there was a close relationship between chemical shifts for 
each residue peptide in water and in DPC.   Using the RCI tool [28] available on 
http://wishart.biology.ualberta.ca, the chemical shifts were used to determine the 
flexibilty and the order parameters, S2, of Anoga_akh (Figure 6.1). 
(a)       (b)    
Figure 6.1: a) Molecular dynamics backbone root mean square deviation and b) order 
parameter, S2, of Anoga_akh calculated using RCI server [28]. 
 
Residue NH Hα β β’ γ γ’ δ δ’ Other 
pGlu1 7.914 4.266 1.880; 2.245; 2.395    
Leu2 8.408 4.300 1.391; 1.513 0.754 0.777  
Thr3 8.092 4.226 4.052 0.995      
Phe4 8.013 4.564 2.933      7.11 92,60; 
7.04 (3,4,5) 
Thr5 7.933 4.338 3.914 0.984      
Pro6 -- 4.118 1.294; 1.793 1.637; 
1.562 
3.391  
Ala7 8.166 4.152 1.198       
Trp8 – 
NH2 










The results show that the N-terminal end from pGlu1 to Phe 4 has higher backbone 
deviations and fluctuations (MD_RMSD ranging from 1.4 -1.7) than the C-terminal 
end (Thr5-Trp8) which has much lower MD_RMSD of 1.1 – 1.2 (Figure 6.1a).   The 
molecule however is generally ordered with order parameters ranging from ~0.72 – 
0.80 (Figure 6.1b).   As expected the highly flexible N-ternimus end is less ordered 
than the C-terminus.   
 
Temperature coefficient and Hydrogen bond formation 
The temperature coefficients of the amide chemical shifts were determined from a  
plot of the chemical shifts against temperature (Appendices H and I).   The 
temperature coefficient is used as an indicator for hydrogen bond formation by amide 
protons (NH) [15].   The chemical shifts, 1H-1H coupling constancts (Hz) and the 
corresponding calculated phi (φ) angles of some residues in Anoga_akh are given in 
Table 6.3. 
 
Table 6.3: HN temperature coefficients (ppb/K), 1H-1H coupling (Hz) and the 
calculated φ  angles. 
Residue HN temperature 
coefficient 
(ppb/K) 
3JHNHα  coupling 
constant (Hz) 






































The temperature coefficient results indicate that the NH of most residues in 
Anoga_akh participate in formation of intramolecular hydrogen bond.    For Ala7, the 
temperature coefficient of 1.6 was the lowest and reveals that its proton is shielded 
from the solvent by the aromatic Trp8 aromatic side chains and therefore should form 
pronounced intramolecular hydrogen bonds. 
Interproton distances  
 Interproton distances from the nOe crosspeaks were calculated by the Isolated Spin 
Pair Approximation (ISPA) method [12], and pseudoatom corrections were done 
according to Wüthrich, 1986 [8]  (Appendices F and G).   ISPA was a suitable 
approximation since short mixing times of 100ms and 150ms were used in NOESY 
and ROESY respectively, and effects of spin diffusion were small [14].    The first 
and second upper limits upper were obtained by adding ~10% and 20% of each of the 
measured distances since nOe measurements are biased towards short internuclear 
distances [15].  Pro6 Hb – Hb1 internuclear distance, 0.18 nm, was used as the 
reference.   Although, in water, 17 distances ranging from ~0.26 – 0.43 nm were 
obtained and 32 distances in DPC, from ~0.27 (Leu2 NH – pGlu1 NH) – 0.74 ( Leu2 
Hd2 - Phe4 H2,6) nm most distances were similar, for example, distance between Leu 
NH and pGlu1 Hb2 was 0.43 nm and 0.42 nm, respectively.   These internuclear 
distances were used in distance restrained MD simulation of Anoga_akh.  
6.4.2: MD simulations of Anoga_akh 
6.4.2.1 Conformational Search  
Interproton distances and restraints obtained from NMR experiments in water were 
used during 10ns MD simulations at 600K in vacuum to search for conformation of 





high energy conformers [13,14,15].   100 structures were collected separated and 
subjected to 0.1ns simulated annealing and energy minimised.  Cluster analysis of the 
structures at 0.2 nm cut-off distance gave one cluster.   The conformation of lowest 
energy was further subjected to 10ns MD in water at 300K.   Another set of 100 
structures was collected and each structure was energy minimised.  Cluster analysis 
gave only one cluster indicating that the confomation of the peptide is highly 











       (a)                                                                                     (b) 
Figure 6.2:  a) An overlay of 100 structures from MD simulations of Anoga_akh in 
water at 300K. b) The minimum energy conformation of Anoga_akh.   The red dotted 
lines indicate a salt bridge between the oxygen atom in Trp8, OH in Leu2 and 
nitrogen in NH2.  
 
The identified minimum energy structure indicates that the peptide prefers a 
cyclic conformation.   The salt bridges between Leu2 and Trp8 atoms and 






was similar to the conformation of Gonadotropic releasing hormones (GnRH) [13] 
and the Crustacean cardioactive peptide (CCAP) [15].  To complete the circle in these 
peptides intramolecular interactions like H-bonds [13] or disulphides bonds as in 
CCAP [15] are used.  Similarly, in Anoga_akh a salt-bridge was used to complete the 
circle.   
 Figure 6.3 shows a comparison between phi angles calculated from 10ns 
trajectory in water, using GROMACS tools [19] and those predicted from the NMR 









Figure 6.3:  Comparison of phi torsion angles calculated from NMR chemical shifts by 
PREDITOR [29], estimated from MD simulations in water and from calculations using 3JHNHα 
coupling constants. 
 
All 100 conformations obtained from the MD simulations, were used in the 
calculation of  the average dihedral angle, phi.   For an average standard deviation of 
~ + 15 for each residue, it was observed that phi angles from MD calculations were 
comparable to the PREDITOR and NMR results.  With the exception of Thr5, MD 
simulations reproduced experimental results.  Therefore the conformation of 






6.4.3 Docking Calculations 
6.4.3.1 AKHR Binding pocket and binding mode of Anoga_akh 
Docking calculations of Anoga_akh to its receptor using Autodock4 programme [23] 
confirmed the position of the binding pocket of adipokinetic hormone receptor 
(AKHR) and the involvement of the extracellular domains in ligand binding as shown 
in Figure 6.4a.    These observations are supported by experimental results from 
mutational mapping of peptide receptor binding site [30,31].  The ligand successfully 
occupied the putative binding pocket and was in contact with residues in helices 2, 3, 









(a)         (b) 
 
Figure 6.4:  a) Side view of bound AKHR (orange) shows the position of Anoga_akh 
(pink) and b) Extracellular view of Anoga_akh/AKHR complex indicating the 
involvement of H2, H3, H5, H6, H7 and ECL2 in ligand binding.   
 
From 30 docking trials, lowest estimated free energy of binding (ΔGb) of -47.3kJ/mol) 
and an inhibition constant of 5.22nM were obtained.   This shows that the receptor 







the blister beetle (ΔGb of -38.5kJ/mol).  However, in this conformation Tyr285 and 
Gln206 participated in stabilising the complex through formation of salt bridges with 
NH2 and Trp8 at the C-terminus of Anoga_akh.   The conformation was used as the 
starting structure in MD simulations of the receptor-ligand complex in its true 
hydrophobic environment. 
 
6.4.4 Membrane simulations of Anoga_akh/AKHR complex 
To refine docking experiments and determine the effect of Anoga_akh on the 
conformation and structural features of AKHR, 100ns MD simulations were 
performed with a flexible receptor-ligand complex inserted in a pre-equilibrated 
POPC membrane model.   Refinement and optimisation of the complex was important 
since docking calculations were performed with a rigid receptor molecule and mobile 
ligand molecule.  MD simulations with both molecules flexibile provided a way of 
determining the stability and binding modes of Anoga_akh in the complex during 
molecular motion. 
 6.4.4.1 Conformational changes in bound AKHR 
The agonist, Anoga_akh, induced conformational and structural changes in the 
receptor molecule during MD simulations as the molecule changed from an ‘open’ to 
a ‘closed’ conformation in the extracellular region, whilst the intracellur region 
opened up.   The differences in conformation between bound and unbound AKHR 
were supported by an rmsd of ~ 0.32 nm obtained from an overlay of Ca atoms of the 
two receptor molecules.   Initial changes in conformation of the receptor in the 
presence of Anoga_akh occurred within the first 2 ns of simulation.   This indicates 





However, the slow transition from inactive to active state of AKHR is similar to the 
rate of conversion of β 2AR when activated by its agonist, adrenaline [33].   In 
comparison, drastic changes occurred in ~1.5 ns in the presence of Del_CC (Chapter 
Five), indicating fast change from inactive to active state by the receptor.    
Figure 6.5 gives a comparison of the flexibilty of the receptor Ca atoms in 
unbound (o_akhr20) and bound AKHR (Anoga_akh/AKHR complex).   The rmsf 
results indicate that there was similar mobility of the atoms in the two receptor 
molecules and high fluctuations were observed in the extracellular and the 
intracellular domains, with rmsf as high as ~0.65 nm.    Although helices average rmsf 
was ~0.1nms, there was increased mobilty of atoms in the extracellular end of H1 (47-
75), and H2 (84-98) which experienced great conformational changes due to ligand 
binding. 












Figure 6.5:  Variations of Root mean square fluctuations of bound (green) and 







 During 100ns MD simulations, movements of the receptor resulted in 
deviations of bound AKHR molecule from its starting structure by an initial rmsd of ~ 















Figure 6.6:  Comparison between molecuar deviations of unbound (black) and 
AKHR bound to Anoga_akh (green) and AKHR bound to Del_CC (blue). 
 
Deviations were due to the inward movement of helices in the extracellular region and 
an outward movemnet in the intracellular side.   The system however attained a steady 
state after ~10ns and this was maintained until the end of simulation.   In contrast, 
AKHR bound to Del_CC had much higher deviations and the drastic change in 
conformation is indicated by an initial rmsd of ~ 0.42 nm, whilst the outward 
movement of helices in unbound AKHR an initial rise to ~0.38 nm.   Of the three 






Comparison of the compactness of the receptor molecule during MD 
simulation showed that unbound and bound molecules had similar compactness for 










Figure 6.7: Comparison of changes in radius of gyration of AKHR bound to 
Anoga_akh (green) and bound to Del_CC (blue) and unbound (back) AKHR during 
100ns MD simulations.  
However, in bound AKHR, there was increase in Rg from ~2.41 to ~2.50 nm from 0 - 
10ns, as helices and the loop domains shifted to accommodate and protect the ligand.     
This sudden rise in Rg, also observed with AKHR bound to Del_CC, corresponds to 
the initial rise of the rmsd shown in Figure 6.6, indicating major movements in the 
receptor.   The molecule remained in the activated state until the end of the simulation 
period maintaining an Rg of ~2.48 nm.   In contrast, unbound AKHR had a sudden 
decrease in Rg from ~ 2.49 to ~ 2.45nm, reflecting an increase in compactness in the 
hydrophobic environment.   The different changes in compactness at the beginning of 
simulation clearly demonstrate that when bound to an agonist, the confomation and 






6.4.4.1.1 Conformational changes in the helix bundle 
From the beginning of the MD simulations, AKHR experienced conformational 
changes, most important of which involved an inward movement of the extracellular 
side of the helix bundle and an outward withdrawal of the intracellular side due to 
activation of the receptor, Figure 6.8.    Such changes in conformation of the helical 
bundle are crucial for transmission of signals from the extracellular to the intracellular 
region of the cell and lead to activation of the G-protein [30,33].   In extracellular 
regions H1, H2, H5 and H6 were drawn closer to each other.   The position of H1 in 
bound AKHR (gray) compared to its location in the unbound molecule reveals an 
inward and upward movement by ~ 0.68 nm.   Similar movements were witnessed by 







Figure 6.8:  An overlay of unbound (brown) and bound (gray) AKHR.  There was an 
inward movement of the helices in the extracellular region, and an outward 
movement in the intracellular region. 
 On the other hand, in the intracellular region there was an outward movement 
of helices 1, 2, 3 and 5 (Figure 6.8).    Experimental results have demonstrated the 
importance of the drift of H6 and H3 away from each [33,34].  The same movement 
was observed in AKHR as it attains an activated state.   Similar movements were also 
observed during activation of rhodopsin [35] and β 2AR [32], where an outward 






the heterotrimeric G-protein.   In AKHR the outward movement resulted in breaking 
of the ionic interactions between H5 and H6, which could increase the basal activity 
of the receptor and initiate activation of G-protein.  
 The inward and outward movements of helices caused the extracellular loop 
domains to collapse over the helix bundle, especially ECL1 and ECL2.  
Consequently, a closed conformation that protected the agonist was produced.   On 
the contrary, the intracellular loop domains were drawn outwards.   Such changes are 
usually found during activation of Class A GPCRs [30,33] and they illustrate that 
Anoga_akh activated the receptor. 
 
Conformational changes in Anoga-akh  
Binding of Anoga_akh to AKHR induced conformation changes from an almost 
cyclic molecule to an L-shaped one (Figure 6.9).  The N-terminus of the ligand was 
very flexible because of few intramolecular interactions.   An overlay of the ligand 








Figure 6.9: Comparison of conformations of Anoga_akh before (deep pink) and after 







In the ligand/receptor complex the conformer is stabilised by H-bonds, salt bridges 
and hydrophobic interaction with the receptor molecule as discussed in the next 
section. 
6.4.4.2 Binding mode and binding affinity of Anoga_akh 
Experimental results from mutational mapping and chimera studies of peptide GPCRs 
have shown that both the helix bundle and the extracellular loop domains participate 
in ligand binding (36,37).   The inward movement of the extracellular side of the helix 
bundles and the collapse of the loop domains brought extracellular residues closer to 
the ligand and binding pocket of AKHR was defined by H2, H3, H5, H6, H7, ECL1 
and ECL2.   Anoga_akh was therefore stabilised by H-bonds, salt-bridges and 
hydrophobic interactions involving residues like Ile106, Tyr110, Phe126, Tyr221, and 











Figure 6.10:  Interactions between Anoga-akh (pink) and some of the residues in 







At instances when no polar contacts were present between the ligand and the 
receptor, the ligand was kept in position by hydrophobic interactions with Tyr110, 
Tyr221, Tyr285, Phe126 (Figure 6.10) and non-polar residues in the N-terminus and 
ECL3.   In addition to the hydrophobic interactions, Tyr285 occassionally formed a 
salt bridge with the nitrogen atom of NH2 at the C-terminus of the ligand, for example 
at 0 and 50ns (Figure 6.10).  The most importatnt residue in binding Anoga_akh was 
Ile106 (H2) which constantly formed H-bonds or a salt-brdge with Thr5 in the ligand.  
Participation of this residue, which was not seen in the initial structure (at 0ns) 
accounts for the inward movement of H2 during dynamics. 
 From the 100ns trajectory of the Anoga_akh/AKHR complex, structures were 
extracted at 10ns interval and rescored to obtain final values of the estimated free 
energy of binding.   Calculations were performed by the modified scoring function of 
Autudock3.0 designed by Hetenyi, 2006 [27].  Table 6.4 gives ∆Gb, inhibiton constant 
(KI) and final binding energy (Eb), obtained from the calculation.    
Table 6.4: Estimated free energy of binding, inhibition constant and final 
binding energy of Anoga_akh   
Anoga_akh 
conformations 









































 (2_10ns denotes the second conformer extracted after 10ns. Other conformers are 
similarly labelled). 
 
The highest binding affinity was obtained after 80ns, ∆Gb of -50.20 kJ/mol 
and the ligand experienced least resistance to binding giving KI of 1.63nM.   The 
conformation had higher affinity than in the initial docking calculations results (∆Gb 
of -47.3kJ/mol).  As shown in Figure 6.10, H-bond between the oxygen atom in 
Ile106 and HG1 atom in Thr5, and hydrophobic interactions stabilise the 
conformation.   This highlighted the importance of Ile106 in binding of Anoga_akh to 
AKHR.   It is important to note that, although binding affinity for Anoga_akh varied 
throughout molecular dynamics, it was much higher (average ∆Gb = -33.92kJ/mol), 
than that for Del_CC (average ∆Gb = -19.02kJ/mol), from blister beetle.  
6.5: Conclusion 
The most stable conformation of adipokinetic hormone from the malaria mosquito 
was determined by using NMR data and distance restrained molecular dynamics 
simulations.  The molecule preferred a cyclic conformation and a salt-bridge 
completed the circle.   Docking calculations of Anoga_akh gave a complex in which 
the ligand occupied a binding pocket described by the helix bundle and the 
extracellular domains.   The Anoga_akh/AKHR complex was stabilised by both polar 
and hydrophobic interactions involving residues in helices and loops.   Ile106 played 
an important role in binding the agonist and the receptor had a very high binding 
affinity for Anoga_akh.  Upon binding, the conformation of the agonist changed from 
cyclic to L-shaped. 
 MD simulations revealed that there was slow conformational change of the 





within the first few nanoseconds.   Subsequently, the intracellular region changed 
from a closed to an open conformation, a change that is crucial in activation of G-
proteins.   Identification of the binding pocket of the mosquito AKHR, binding 
affinity and binding mode of Anoga_akh should go a long way in the design of non-
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Summary and Conclusions 
7.0: Summary 
G-protein coupled receptors occupy a central position in the physiology of insects and 
are excellent drug targets in humans [1].   The 3D structures of the receptors are 
crucial for ligand binding but to date no 3D structure of an insect G-protein coupled 
receptor (GPCR) is available.   Knowledge of the 3D structure of the GPCR for 
adipokinetic hormone (AKHR) from the malaria mosquito is crucial for the 
development of insect specific insecticides.  Since the determination of structures of 
GPCRs using experimental methods has proved to be very difficult, computational 
molecular modelling was used to build 3D structures of AKHR.  
 
7.0.1 Three-dimensional structures of AKHR  
 From the genome of Anopheles gambiae, the primary sequence of a putative GPCR 
of AKH was identified and recently published [2,3].  From the PSIPRED and 
MEMSAT3 predictions, it was found that the receptor has seven transmembrane 
helices consisting of 218 residues.   The primary sequence was used to construct two 
models of the receptor using homology modelling to build the 7 transmembrane helix 
bundles based on the crystal structures of beta2-adrenergic receptor (β2AR) [4] and 
rhodopsin [5].  Conformational search of the flexible loop regions was performed 
using high temperature simulated annealing and restrained molecular dynamic 
simulations.   The rhodopsin-based and β 2AR-based AKHR molecules (Figure 7.1) 
were obtained by joining the loops to their respective helices and optimising the 
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Figure 7.1:  a) The beta2 based structure and b) the rhodopsin-based structure.    
The molecular models have similar overall structures and both have an 
anticlockwise arrangement of seven α -helices.   Both contain the cystein-cystein 
disulphide bond and the eighth helix that is found in most Class A GPCRs.  The 
7TMs are stabilised by interhelical interactions involving the highly conserved 
residues [6], for example Asp94 (H2) and Asn319 (H7).   As with most GPCRs, the 
helices are characterised by kinks that provide flexible hinges for conformational 
change during activation of the receptor [7] especially Met, Thr or Tyr precedes 
proline [8]    
An overlay of the models reflected that, there are marked differences (rmsd of 
0.79 nm) in the two molecular models.    Most importantly, the rhodopsin-based 
model has a ‘closed’ extracellular region while the β2AR-based structure is ‘open’.    
Since rhodopsin has a closed structure that protects its covalently bound ligand [5], it 
was postulated that the β2AR-based structure symbolizes the unbound form of AKHR 
whilst the rhodopsin-based represents the bound form.    In addition, helices in the 






terminus, and a helix in the N-terminus.  These features are not found in the 
rhodopsin-based structure.    
The rhodopsin-based and β2AR-based AKHR molecules were refined by 
performing extensive MD simulations in a POPC membrane to mimic the receptor’s 
true environment.   Both molecules were very stable during simulations and the 
overall structure was maintained.  The membrane played an important role in 
stabilising the helical bundle.   Upon optimisation of the β2AR-based AKHR 
molecule, in the extracellular region, helices moved apart (Figure 4.5).   This resulted 
in a wider extracellular region than in the template, leaving a cavity for ligand 
binding.   Also the N-terminus was ordered and consistently formed a helical turn 
from Glu32-Tyr35 (Figure 4.6) and β -strands involving Tyr24-Tyr25.   Similar 
features were also found in the third intracellular loop (Figure 4.6).     On the other 
hand, the rhodopsin-based molecule maintained the closed conformation with a slight 
outward shift of the helices (Figure 4.12).   The ionic bond found between H3 and H6 
was broken during simulations (Figure 4.13).   A helical turn was also found in the N-
terminus and the third intracellular loop (Figure 4.14 and 4.15).   The opening up of 
the β 2AR-based AKHR supports the idea that the molecule represents the unbound 
form of the receptor. 
 
7.0.2 Binding pocket and Activity of AKHR 
Separate docking calculations with adipokinetic hormones from Anopheles gambiae 
(Anoga_akh (pQLTFTPAWa)), modelled based on interproton distances from NMR 
experiments, and the blister beetle (Del_CC (pQLNFSPNWGNa)) [9], show that helix 





The binding pocket is defined by helices 2, 3, 5, 6 and 7, the second and third 










Figure 7.2 Comparison of the position of Anoga_akh (pink) and Del_CC (blue) in 
the receptor, AKHR.  Conformations of the receptor after activation are shown by 
green (Del_CC activated) and gray (Anoga_akh activated) ribbons.  
 
The binding pocket in the ‘open’ β 2AR-based model was easily accessed by the 
ligands, thus hormone binding was facilitated.   
Molecular dynamics of the ‘open’ β 2AR-based AKHR/ligand complex have 
revealed that the receptor ‘closes’ up in the extracellular region upon activation.   In 
the intracellular region, helices ‘open’ up, moving H3 and H6 apart from each other.   
The moving apart of these helices is crucial for receptor activation [1].   In the 
presence of Anoga_akh, there was a slow change from inactive to active receptor, a 
behaviour also observed in the activation of β2AR by adrenaline [10].   On the other 
hand, Del_CC induced fast conformational changes in the receptor and the helices 
were drawn much closer to each other.   Such a response to ligand binding was also 






conformation due to ligand binding illustrate that inactive AKHR has an ‘open’ 
conformation whilst the activated form is ‘closed’.    
Binding of the ligands involved ionic as well as hydrophobic interactions with 
residues in the helix bundle and the second extracellular loop.  Del_CC formed ionic 
bonds with mostly Tyr110, Gln209, Tyr221 and Tyr285.    It was observed that 
Tyr285 was crucial for binding Del_CC.   This ligand is more polar than Anoga_akh 
and contains two Asn residues that were pivotal in binding.   On the other hand Ile106 
was important for binding of Anoga_akh through Thr5.  Due to low polarity of 
Anoga_akh, the aromatic side chains of Phe126 and the three Tyr residues helped to 
stabilise the ligand through hydrophobic contacts.  
Although Anoga_akh slowly induced conformational changes, binding affinity 
for this ligand was higher than for Del_CC.   This is evidenced by the initial estimated 
free energy of binding (ΔGb) of -47.3kJ/mol for Anoga_akh compared to -38.9 kJ/mol 
for Del_CC.    During molecular dynamics of the ligand/receptor complexes, average 
ΔGb for Anoga_akh was ~ -33.92 kJ/mol (Table 6.3), whilst that for Del_CC was ~ -
19.02 kJ/mol (Table 5.1).   Differences in binding affinity, binding mode and the 
response of the receptor when activated by different ligands could imply receptor 
selectivity.   
 
7.1 Conclusions 
In this thesis, the primary sequence of an adipokinetic hormone receptor from the 
malaria mosquito, Anopheles gambiae, was successfully used to construct two 3D 
structures of the receptor, the rhodopsin-based and the beta2-adrenergic-based 





models are in agreement with most mutational data and could give an insight into the 
3D structures of insect GPCRs.   However, the beta2-adrenergic receptor has an 
‘open’ conformation that represents the unbound form of the receptor but does not 
have the ‘ionic-lock’.   The rhodpsin-based structure is ‘closed’ and symbolises the 
bound form of the adipokinetic hormone receptor.  
During membrane MD simulations to optimise the models, the β2AR-based 
molecule attained a wider helix bundle that maintained the ‘open’ conformation.     
The change in conformation indicates the differences between the model and its 
template.   On the other hand, there was a slight outward shift of helices in the 
rhodopsin-based structure and the ‘closed’ conformation was also preserved.      The 
ionic bond involving the highly conserved Arg146 was broken as helices separated.    
The highly flexible N-terminus and third intracellular loop are structured and they 
consistently formed β -sheets and helical turns, especially in β2AR-based AKHR.   
These structural features could be important in ligand binding and receptor activation.    
Docking calculations of insect adipokinetic hormones, Del_CC, from the 
blister beetle and Anoga_akh, from Anopheles gambiae, revealed that the helix 
bundles, the extracellular loop domains and the N-terminus describe the binding site 
of the adipokinetic hormone receptor.   This observation is in agreement with 
experimental results from mapping of the binding sites in peptide GPCRs.  On the 
other hand, rhodopsin and beta2-adrenergic receptors have their binding sites inside 
their helix bundles.   The ‘open’ conformation facilitated ligand binding by providing 
easy access to the binding pocket, whilst the binding pocket in the ‘closed’ molecule 
could not be accessed by the ligands from outside the receptor.    
MD simulations of the adipokinetic hormone receptor/ligand complex have 





conformation in the extracellular side.    Simultaneously, the intracellular side of the 
receptor ‘opened’ up as the ligands activated the receptor.   The mosquito adipokinetic 
hormone induced a slow conversion of the receptor from inactive to active form and 
had high binding affinity.   In contrast, Del_CC caused fast and drastic changes in 
conformation but had low binding affinity.    In the adipokinetic hormone receptor 
Tyr285 was importance in binding Del_CC whilst Ile106 played a crucial role in 
binding of Anoga_akh.    From these observations it can be concluded that the beta2-
adrenergic receptor represents the unbound form of the receptor whilst the rhodpsin-
based molecule represents one of its activated states.  
Although at atomic-level, the molecular model of AKHR and AKHR/AKH 
might differ from the structures determined by x-ray crystallography or by NMR 
spectroscopic methods, they can be reliably used for further studies of insect GPCRs.   
Since adipokinetic hormone receptor is involved in the generation of energy during 
insect flight, knowledge of its 3D structure, binding site and activity could lead to the 
design of non-peptide mimetics that can block the binding pocket and lead to the 
development of species specific insecticides.   Hence, by using genomic information 
to build the structure of the receptor and determine its activity, the fight against 
malaria could be enhanced. 
 
7.2 Future work 
Molecular dynamic simulations of G-protein coupled receptors in a membrane are 
presently carried out for more than 500 ns, therefore it would necessary to perform 
longer simulations using bigger computer clusters and/or the Coarse grained 






The information obtained in this work could be used in designing agonists and 
antagonists that block the binding site and give insect specific insectides. 
Once adipokinetic hormone receptor is bound to a G-protein inside the cell, docking 
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Appendix A  




 AA:  MPNTMAAHINQRIEDHRNLLADWSYYANETAGEEYYEMPIDMRFNSGHILSIMVYTTLMV 
              10        20        30        40        50        60 
Conf: 999989996578885588779778999999999999999998679999999619655137 
Pred: HHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCEECHH 
 AA:  FSATGNLTVLSILAQRKVRASSRINIMLAHLAIAADLLVTFLMMPLEIGWAYTVRWTAGD 
              70        80        90       100       110       120 
Conf: 999999999999999999999999988106897037676114779989999999999857 
Pred: HHHHHHHHHHHHHHHHHHHHHHHHHHHHEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHH 
 AA:  LMCRVMAFFRTFGLYLSSFILICISVDRYFAVLKPLKVHEHRAVLMIAAAWIMSGLCSLP 
             130       140       150       160       170       180 
Conf: 764467888506899659998189967999999999999999999999999999999999 
Pred: HHHEEEEEEECCCCCCEEEEEECCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH 
 AA:  QAFIFHLEGHPNITGYQQCVTYHYFEEEIYQIIYNVLVMCLMYTFPLIVILCYGSIYYEI 
             190       200       210       220       230       240 
Conf: 987602444210011034678889999999999999999997679999999996465565 
Pred: HHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCC 
 AA:  FSRTNPRNLESFRRSSIDVLGRAKRKTLRMTIMIVIVFVVCWTPYYVMSLWYWLDKESAK 
             250       260       270       280       290       300 
Conf: 5679999999999999987879999814899999999985658888288588999 
Pred: CHHHHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHCCCCCCCCCCCCCCC 
 AA:  NVDQRIQKGLFLFASTNSCMNPVVYGVFNVRKKHTKKLLKTTHEKSCGSHLTMRA 
 
  
Conf: Confidence (0=low, 9=high), Pred: Predicted secondary structure (H=helix, 
E=strand, C=coil), AA: Target sequence.   Blue shows a predicted helix in the n- 
terminus, red indicates residues in the seven transmembrane helices, cyan shows the 









Sequence alignment of AKHR and Beta2 helices. 
 
akhrTm1             --HILSIMVYTTLMVFSATGNLTVLSILAQRK  30      
2RH1a               DEVWVVGMGIVMSLIVLAIVFGNVLVITAIAK  32  
                        :  *  .  ::. *. . .** * *  *              
akhrTM2             -INIMLAHLAIADLLVTFLMMPLEIGWAYT  29     
2RH1A               VTNYFITSLACADLVMGLAVVPFGAAHILM  30 
                     .  :     .***:: : ::*:  . 
akhrTM3             --LMCRVMAFFRTFGLYLSSFILICISVDRYF---     30 
2RH1a               GNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAIT     35 
                      : *.. : : .: :  *   *  *:*****  
akhrTM4             EHRAVLMIAAAWIMSGLCSL----    20 
2RH1a               KNKARVIILMVWIVSGLTSFLPIQ   24 
                    :::* ::*  .**:*** *:             
akhrTM5             --YNVLVMCLMYTFPLIVILCYGSIYYEIFSR---     30      
2RH1a               QAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLK     35 
                      * :      : .**::::  :*: :: ..*                             
akhrTM6             -KRKTLRMTIMIVIVFVVCWTPYYVMSLWYWL  31       
2RH1a               KEHKALKTLGIIMGTFTLCWLPFFIVNIVHVI  32 
                     ::*.*:   :*  .*.:** *::::.: : :              
akhrTM7             ------LFLFASTNSCMNPVVYG   17       
2RH1a               KEVYILLNWIGYVNSGFNPLIYC   23       
                      :   *  :. .** :**::*        
akhrTM8       NVRKKHTKKLLK-    12  
2RH1a       RDFRIAFQELLCL    13 
                    :   ::** 
 
AkhrTM1-8 are residues in AKHR helices, 2RH1a indicate residues in beta2 helices. 
Asterisk (*) indicates identical residues aligned, and colon (:) and dots (.) indicate 












Appendix C  
Sequence alignment of AKHR and Rhodopsin helices 
 
akhrTM1         ---HILSIMVYTTLMVFSATGNLTVLSILAQ  28      
1f88A           PWQFSMLAAYMFLLIMLGFPINFLTLYVTVQ  31 
                   . :       *:::  . *: .*.: .* 
akhrTM2         -INIMLAHLAIADLLVTFLMMPLE------  24        
1f88A           PLNYILLNLAVADLFMVFGGFTTTLYTSLH  30 
                 :* :* :**:***::.*  :        
akhrTM3         GDLMCRVMAFFRTFGLYLSSFILICISVDRY---  31        
1f88A           GPTGCNLEGFFATLGGEIALWSLVVLAIERYVVV  34 
                *   *.: .** *:*  :: : *: ::::** 
akhrTM4         EHRAVLMIAAAWIMSGLCSLP---   21    
1f88A           ENHAIMGVAFTWVMALACAAPPLV   24 
                *::*:: :* :*:*:  *: *   
akhrTM5         EIYQIIYNVLVMCLMYTFPLIVILCYGS-  26 
1f88A           ETNNESFVIYMFVVHFIIPLIVIFFCYGQ  27 
                *  :  : : :: : : :*****:  :.  
akhrTM6         RAKRKTLRMTIMIVIVFVVCWTPYYVMSLWYW-  32        
1f88A           KAEKEVTRMVIIMVIAFLICWLPYAGVAFYIFT  33 
                :*:::. **.*::**.*::** **  :::: : 
akhrTM7         --IQKGLFLFASTNSCMNPVVYG   21        
1f88A           PIFMTIPAFFAKTSAVYNPVIYI   23 
                  : .  .:**.*.:  ***:*   
akhrTM8         NVRKKHTKKLLKTT    14   
1F88a           MMNKQFRNCMVTTL    14 
                 :.*:. : ::.*   
 
1F88a indicate residues in rhodopsin helices.  Asterisk (*) indicates identical 
residues aligned, and colon (:) and dots (.) indicate similar residues. Number of 












Blind docking parameters of Del_CC to AKHR.   
Parameter and quantity    Description    
outlev 1                              
intelec                              # calculate internal electrostatics  
seed pid time                        # seeds for random generator 
ligand_types A C HD OA N             # atoms types in ligand 
fld akhr_11_1.maps.fld               # grid_data_file 
map akhr_11_1.A.map                  # atom-specific affinity map 
map akhr_11_1.C.map                  # atom-specific affinity map 
map akhr_11_1.HD.map                 # atom-specific affinity map 
map akhr_11_1.OA.map                 # atom-specific affinity map 
map akhr_11_1.N.map                  # atom-specific affinity map 
elecmap akhr_11_1.e.map              # electrostatics map 
desolvmap akhr_11_1.d.map            # desolvation map 
move akh_11_1.pdbqt                  # small molecule 
about 13.6675 28.2697 20.9725        # small molecule center 
tran0 13.668 28.270 20.973           # initial coordinates/A or random 
quat0 random                         # initial quaternion 
ndihe 30                             # number of active torsions 
dihe0 random                         # initial dihedrals (relative) or random 
tstep 2.0                            # translation step/A 
qstep 50.0                           # quaternion step/deg 
dstep 50.0                           # torsion step/deg 
torsdof 32 0.274000                   # torsional degrees of freedom and coefficient 
rmstol 2.0                           # cluster_tolerance/A 
extnrg 1000.0                        # external grid energy 
e0max 0.0 10000                      # max initial energy; max number of retries 





ga_num_evals 100000000               # maximum number of energy evaluations 
ga_num_generations 100000000         # maximum number of generations 
ga_elitism 1                         # number of top individuals to survive to next generation 
ga_mutation_rate 0.02                # rate of gene mutation 
ga_crossover_rate 0.8                # rate of crossover 
ga_window_size 10                    #  
ga_cauchy_alpha 0.0                  # Alpha parameter of Cauchy distribution 
ga_cauchy_beta 1.0                   # Beta parameter Cauchy distribution 
set_ga                               # set the above parameters for GA or LGA 
sw_max_its 300                       # iterations of Solis & Wets local search 
sw_max_succ 4                        # consecutive successes before changing rho 
sw_max_fail 4                        # consecutive failures before changing rho 
sw_rho 1.0                           # size of local search space to sample 
sw_lb_rho 0.01                       # lower bound on rho 
ls_search_freq 0.06                  # probability of performing local search on individual 
set_sw1                              # set the above Solis & Wets parameters 
compute_unbound_extended             # compute extended ligand energy 
ga_run 10                            # do this many hybrid GA-LS runs 
analysis                             # perform a ranked cluster analysis 
















Refined docking parameters using beta2 – based model and Del_CC. 
 
Parameter and quantity    Description    
move akh_12.pdbqt                    # small molecule 
ndihe 32                             # number of active torsions 
torsdof 32 0.274000                   # torsional degrees of freedom and coefficient 
ga_pop_size 300                      # number of individuals in population 
ga_num_evals 500000000               # maximum number of energy evaluations 
ga_num_generations 500000000         # maximum number of generations 
ga_run 100                           # do this many hybrid GA-LS runs 
analysis                             # perform a ranked cluster analysis 
These parameters were used in addition to the Autodock4 default parameters as 

















Interproton distances from NMR (nm) used during Molecular dynamic simulations. 
pGlu-LTFTPAW-NH2 peptide in H2O-D2O 10:1,  pH ca. 4 (phosphate buffer)  
T=290K, ROESY 150 ms  (*in brackets: pseudoatom corrections according to:  
Wüthrich, K., NMR of Proteins & Nucleic Acids, p. 178, Wiley 1986) 
Distances represent lower limits between protons/pseudoatoms involved. 
Proton 
Number  Assignment 
Distance (Ǻ) 
corrected* 
    
1  LNH-pEbb’ 4.3(m) 
    
2  ANH-Pbb’ 4.7(m) 
    
3  FNH-T3g 4.3(m) 




    
6  T5NH-Fbb’ 4.0(m) 
    
7  WNH-Aa 3.3(m) 
    
8  WNH-Ab 3.1 
    
9  CONH2a-Wbb’ 4.2(m) 
    
10  CONH2a-Wa 2.6 
    
11  CONH2b-Wa 3.7 
    
12  LNH-T3NH 2.8 
    
13  FNH-T3NH 2.8 
    
14  LNH-pENH 3.2 
    
15  ANH-WNH 3.0 
    
16  T5a-Pd.d' 3.6(m) 
    
17  T5b-Pd,d' 3.6(m) 
    








pGlu-LTFTPAW-NH2 peptide H2O-D2O 9:1, DPCC micelles in pH ca. 4  
phosphate buffer,  T=290K, NOESY 100 ms 
(*in brackets: pseudoatom corrections according to:  
Wüthrich, K., NMR of Proteins & Nucleic Acids, p. 178, Wiley 1986) 
Long-range contacts in red 





1 LNH-pEbb’ 4.2(m) 
   
3 ANH-Pb 3.9(m) 
   
4 T3NH-Lbb’ (or g) 3.9(m) 
   
6 T3NH-Ldd' 5.2(q) 
   
7 FNH-T3g 3.8(m) 
   
8 FNH-Lbb’ (or g) 4.4(m) 
   
10 T3NH-La 3.0 
   
12 FNH-T3b 3.6(m) 
   
12a FNH-T3a 3.0 
   
13 T5NH-Fa 3.0 
   
14 T5NH-Fbb’ 3.5(m) 
   
15 WNH-Aa 3.0 
   
16 WNH-Ab 3.5(m) 
   
17 Ldd'-F2,6 7.4(qr) 
   
18 Ldd'-F3,4,5 7.2(qr) 
   
19 T3g-F3,4,5 6.5(qr) 
   
20 T3g-F2,6 7.0(mr) 
   
21 T5g-W2 5.4(m) 
   
22 Ab-W2 4.4(m) 
   
23 Lbb’ (or g)-F3,4,5 6.3(mr) 
   





   
26 Lbb’ (or g)- F2,6 6.5(mr) 
   
27 Pgg’ (or bb’)-F2.6 6.0(mr) 
   
29 LNH-T3NH 2.9 
   
30 LNH-pENH 2.7 
   
31 ANH-WNH 2.7 
   
32 T5NH-F3,4,5 5.0(r) 
   
36 T5a-Pdd' 3.7(m) 
   
37 T5b-Pdd' 3.9(m) 
   
38 Wb-Ab 5.6(mm) 
   
40 T5a-Pbb’ 4.3(m) 
   













































   
 
 
 
 
